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RESUMO	
	
O	 envelhecimento	 tornou‐se	 uma	 das	 grandes	 preocupações	 das	 sociedades	
modernas,	 devido	 ao	 seu	 elevado	 impacto	 social	 e	 económico.	 Por	 isso,	 tem	 sido	
amplamente	 investigado	 com	 o	 intuito	 de	 organizar	 estratégias	 capazes	 de	 retardar	 a	
deterioração	do	estado	de	saúde	e	o	aparecimento	de	doenças	associadas	à	 idade.	Neste	
cenário,	 é	 fundamental	 identificar	potenciais	 intervenientes	e	desvendar	os	mecanismos	
moleculares	subjacentes	que	se	encontram	implicados	no	processo	de	envelhecimento.	
Ao	 nível	 celular,	 sabe‐se	 que	 o	 processo	 é	 caracterizado	 pela	 acumulação	
progressiva	de	biomoléculas	oxidadas	que	eventualmente	levam	à	disfunção	celular.	Entre	
as	 condições	 que	 favorecem	 esse	 processo	 encontram‐se	 alterações	 na	 homeostasia	 de	
metais,	que	resultam	no	seu	aumento	ou	acumulação	em	células	e	tecidos,	onde	promovem	
a	formação	de	espécies	reactivas	de	oxigénio	(ROS),	capazes	de	danificar	biomoléculas.	Na	
verdade,	 foi	 já	 descrito	 que	 os	 níveis	 de	 cobre	 aumentam	 com	 o	 envelhecimento	 e	 em	
entidades	clínicas	associadas	à	idade,	tais	como	a	diabetes	tipo	II,	a	aterosclerose	e	doenças	
neurodegenerativas,	 corroborando	 a	 contribuição	 do	 cobre	 para	 o	 stress	 oxidativo	 e	 o	
declínio	funcional.	
Os	 modelos	 celulares	 de	 senescência	 in	 vitro	 são	 essenciais	 para	 o	 estudo	 dos	
eventos	moleculares	implicados	no	processo	do	envelhecimento.	Modelos	de	senescência	
prematura	 induzida	 pelo	 stresse	 (SIPS)	 são	 frequentemente	 utilizados,	 uma	 vez	 que	
apresentam	várias	vantagens	quando	comparados	com	o	modelo	clássico	de	senescência	
replicativa	(RS):	demoram	menos	tempo	a	ser	estabelecidos,	são	mais	fáceis	de	manipular	
e	 apresentam	 uma	 resposta	 celular	 heterogénea	 semelhante	 ao	 que	 acontece	 in	 vivo.	 O	
indutor	 de	 SIPS	mais	 frequentemente	 utilizado	 é	 o	 peróxido	 de	 hidrogénio	 (H2O2),	mas	
outros	indutores	de	stresse	oxidativo	podem	ser	utilizados	com	sucesso.	
Atendendo	à	capacidade	do	cobre	para	promover	a	 formação	de	radicais	 livres,	é	
aqui	 descrito	 pela	 primeira	 vez	 que	 a	 incubação	 de	 fibroblastos	 WI‐38	 com	 uma	
concentração	sub‐citotóxica	de	sulfato	de	cobre	(CuSO4)	é	capaz	de	induzir	SIPS.	De	facto,	
as	células	tratadas	com	o	cobre	exibem	características	típicas	do	fenótipo	senescente,	que	
incluem	 as	 alterações	 morfológicas,	 o	 aumento	 da	 beta‐galactosidase	 associada	 a	
senescência	(SA	βgal),	a	inibição	da	proliferação	celular	e	o	aumento	da	expressão	de	genes	
e	proteínas	associadas	à	senescência.	
Acresce	 que	 o	 estabelecimento	 do	 novo	modelo	 de	 CuSO4‐SIPS	 permitiu	 estudar	
mecanismos	 moleculares	 subjacentes	 à	 contribuição	 do	 cobre	 para	 o	 processo	 de	
envelhecimento.	 Um	 destes	 mecanismos	 relaciona‐se	 com	 a	 perda	 de	 proteostasia,	
considerada	uma	das	principais	características	do	envelhecimento.	Assim,	 formulou‐se	a	
hipótese	de	que	na	senescência	celular	a	proteostasia	altera‐se	e	são	activados	mecanismos	
celulares	 compensatórios,	 como	 a	 resposta	 do	 retículo	 endoplasmático	 (ER)	 a	 proteínas	
com	conformação	anómala	(UPR).	Os	resultados	evidenciam	que	os	modelos	de	RS	e	CuSO4‐
SIPS	 exibem	 alterações	 moleculares	 semelhantes	 ao	 nível	 do	 ER,	 em	 contraste	 com	 as	
observadas	 no	 modelo	 de	 H2O2‐SIPS.	 Além	 disso,	 para	 ambos	 os	 modelos	 SIPS	 é	
demonstrado	 que	 a	 activação	 da	 UPR	 do	 ER	 é	 necessária	 para	 a	 indução	 do	 fenótipo	
senescente.	No	entanto,	enquanto	a	inibição	do	ciclo	celular	induzida	pelo	CuSO4	depende	
da	ativação	da	UPR	mediada	pela	PERK,	isso	não	se	verifica	no	modelo	H2O2‐SIPS.	Assim,	no	
que	diz	respeito	aos	mecanismos	moleculares	envolvidos,	o	modelo	CuSO4‐SIPS	mostrou	ser	
mais	semelhante	ao	RS	do	que	o	modelo	H2O2‐SIPS,	o	mais	frequentemente	utilizado.	
Com	o	objetivo	de	desvendar	potenciais	mecanismos	moleculares	anti‐senescência,	
o	composto	polifenólico	antioxidante	resveratrol,	conhecido	por	apresentar	propriedades	
anti‐envelhecimento,	foi	utilizado.	Da	suplementação	com	resveratrol	resultou	a	atenuação	
do	 aparecimento	 de	 alterações	 típicas	 da	 senescência	 induzidas	 pelo	 CuSO4	 ao	 nível	 da	
morfologia	celular,	da	actividade	da	SA	βgal	e	da	proliferação	celular.	Além	disso,	os	efeitos	
benéficos	do	resveratrol	mostraram	ser	independentes	da	regulação	de	genes	e	proteínas	
associadas	à	senescência,	mas	depender	da	melhoria	da	proteostasia	celular.	Na	verdade,	o	
resveratrol	atenuou	o	aumento	do	teor	de	proteína	total	e	de	BiP	 induzido	pelo	cobre,	e	
reduziu	o	nível	de	proteínas	carboniladas	e	poli‐ubiquitinadas,	pela	indução	de	autofagia	
lisossomal.	
No	seu	conjunto,	os	resultados	apresentados	nesta	tese	apoiam	a	intervenção	activa	
de	cobre	no	processo	de	envelhecimento,	e	propõem		um	modelo	celular	que	provou	ser	
semelhante	aos	modelos	de	RS	e	SIPS	anteriormente	reconhecidos.	Além	disso,	verificou‐se	
que	 a	 contribuição	 de	 cobre	 para	 o	 envelhecimento	 é	 acompanhada	 pela	 ativação	 de	
processos	biológicos	compensatórios,	que	visam	promover	a	proteostasia	celular.	Estamos	
convencidos	 de	 que	 a	 identificação	 de	 alvos	 moleculares	 específicos,	 que	 medeiam	 a	
senescência	 celular	 e	 são	 passíveis	 de	 ser	 modulados,	 terá	 grande	 relevância	 para	 o	
desenvolvimento	 de	 estratégias	 destinadas	 a	 atenuar	 os	 processos	 de	 deterioração	
relacionados	 com	 o	 aumento	 da	 idade	 e	 melhorar	 o	 estado	 de	 saúde	 durante	 o	
envelhecimento.	
	 	
ABSTRACT
Ageing became a major concern of modern societies due to its vast social and 
financial impact. Therefore, it has been widely investigated in an attempt to find strategies 
able to delay the age-related health deterioration and the establishment of diseases. In this 
setting, it is crucial to identify potential contributors and unravel their inherent molecular 
mechanisms implicated in the ageing process. 
At the cellular level, it is characterized by the progressive accumulation of 
oxidatively damaged biomolecules that ultimately lead to cellular dysfunction. Among the 
conditions favoring the process may be the alterations on metal homeostasis that result in 
their increased levels or accumulation within cells and tissues, where they foster the 
generation of reactive oxygen species (ROS) that target biomolecules. In fact, enhanced 
copper levels were reported during ageing and in age-associated diseases such as type II 
diabetes, atherosclerosis and neurodegenerative disorders, further supporting the 
contribution of copper for oxidative stress and the overall age-related functional 
deterioration. 
In vitro cellular models of senescence are essential to study molecular events during 
the ageing process. Stress-induced premature senescence (SIPS) models are frequently 
employed as they present various advantages when compared to the classical replicative 
senescence (RS) model: they are faster to obtain, easier to manipulate and exhibit a 
heterogeneous cellular response similar to the in vivo condition. The most frequently used 
SIPS inducer is hydrogen peroxide (H2O2), but other oxidative stress inducers may be 
successfully employed. 
Based on copper ability to mediate the formation of free radicals, the current work 
reported, for the first time, that incubation of WI-38 fibroblasts with a subcytotoxic 
concentration of copper sulfate (CuSO4) induces SIPS. In fact, CuSO4-SIPS fibroblasts exhibit 
typical senescent phenotype features, including altered morphology, increased 
senescence-associated beta-galactosidase (SA βgal), cell proliferation inhibition and 
several senescence-associated genes and proteins upregulation.  
In addition, the establishment of the novel CuSO4-SIPS model allowed to study the 
molecular mechanisms underlying copper contribution to the ageing process. One such 
mechanism relates to proteostasis disruption, considered a major hallmark of ageing. Thus, 
it was hypothesized that proteostasis was altered during cellular senescence and 
compensatory mechanisms as the endoplasmic reticulum (ER) unfolded protein response 
(UPR) would be activated. The studies evidenced that both RS and CuSO4-SIPS models 
exhibit similar ER molecular alterations, in contrast to the data shown for H2O2-SIPS model. 
Moreover, for both SIPS models it is shown that ER UPR activation is required for the 
induction of the senescent phenotype. However, while CuSO4-induced cell cycle arrest 
depends on PERK-mediated UPR activation, this was not verified to H2O2-SIPS condition. 
Therefore, regarding the molecular mechanisms involved, CuSO4-SIPS model proved to be 
more similar to RS than the most frequently used H2O2-SIPS. 
Aiming at unraveling potential anti-senescence molecular mechanisms, the 
polyphenolic antioxidant compound resveratrol, known to exhibit anti-ageing properties, 
was used. Resveratrol supplementation was shown to attenuate the appearance of CuSO4-
induced typical senescence alterations on cell morphology, SA βgal activity and cell 
proliferation. Moreover, the beneficial effects of resveratrol were shown to be independent 
of the regulation of some senescence-associated genes and proteins, but to require the 
improvement of cellular proteostasis. In fact, resveratrol attenuated copper-induced 
increased levels of total protein content and BiP chaperone and reduced carbonylated and 
poly-ubiquitinated proteins by lysosomal autophagy induction. 
Altogether, the results presented in this thesis support the active intervention of 
copper in the ageing process, and propose a valuable cellular model that proved to be 
similar to the previously recognized RS and SIPS models. Moreover, it was found that the 
contribution of copper to ageing is accompanied by the activation of compensatory 
biological processes that aim at promoting a balanced cellular proteostasis. We are 
convinced that the identification of specific molecular targets that mediate cellular 
senescence, and are ameanable to modulation, will have major relevance for the 
development of strategies intended to attenuate age-related deterioration processes and 
enhance human healthspan. 
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   I 
    INTRODUCTION

The progressive ageing of modern societies’ population constitutes a major concern 
due to its vast social and economic implications. Ageing is not a disease but it increases the 
susceptibility to disease, as it is accompanied by a gradual deterioration in overall functions 
leading to increased vulnerability and occurrence of entities such as cancer, type II diabetes, 
neurodegenerative diseases and cardiovascular disease caused by atherosclerosis. 
The ageing process has been characterized as consequent to a progressive 
accumulation of oxidatively damaged biomolecules within cells that ultimately impinges on 
their function. It is unknown what triggers the process, which would direct us to the 
profound causes of ageing, but an imbalance in metal homeostasis is a likely condition. 
Indeed, some metals as copper or iron are contributors to ROS generation that target most 
biomolecule classes afterwards. It was shown that copper levels increase with ageing in rat 
brain and serum (Fu et al., 2015), bovine brain (Zatta et al., 2008) and human serum 
(Harman, 1965, Sohler and Pfeiffer, 1987). Moreover, alterations in copper homeostasis 
have also been reported in age-associated pathologies, such as atherosclerosis (Apostolova 
et al., 2003), type II diabetes (Eaton and Qian, 2002) and neurodegenerative disorders, as 
Huntington (Fox et al., 2007), Parkinson (PD; Rasia et al., 2005) and Alzheimer (AD; James 
et al., 2012) diseases. In fact, increased level of free serum copper was described for PD 
(Jimenez-Jimenez et al., 1992) and AD (Brewer et al., 2010), adding further evidence to the 
role of copper-induced oxidative stress in the etiology of these neurodegenerative diseases. 
Altogether, the data favour the involvement of this redox active metal in the overall 
deterioration process that is associated with ageing.  
Unravelling the molecular mechanisms underlying the contribution of copper to the 
ageing process may therefore bring further insights to the identification of therapeutic 
targets aiming at attenuating age-related deterioration processes. 
1. THE HALLMARKS OF AGEING
Since long ago, ageing has been subjected to scientific scrutiny in order to expand 
the knowledge of its inherent molecular and cellular mechanisms. It is widely accepted that 
the general cause of ageing is the time-dependent accumulation of cellular damage; 
however pivotal questions have arisen regarding the physiological sources of such damage, 
the compensatory responses that are activated and the possibility to delay ageing by 
exogenous interventions. In a noteworthy review published in Cell (López-Ótin et al., 2013), 
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nine cellular and molecular hallmarks of ageing were identified and generally considered to 
contribute to the ageing process and to determine its phenotype (Figure 1). Therein, the 
authors referred the occurrence of genomic instability, telomere attrition, epigenetic 
alterations and loss of proteostasis as primary hallmarks of ageing, as all these events are 
clearly negative and may be the initiating causes of cellular damage. Then, deregulated 
nutrient sensing, mitochondrial dysfunction and cellular senescence were pointed as 
antagonistic hallmarks because, depending on their intensity they might have opposite 
effects. At low levels, they are beneficial and consist of compensatory responses to cellular 
damage, but as the primary hallmarks persist or intensify, their level rises, they become 
deleterious and generate further damage. At last, stem cell exhaustion and altered 
intercellular communication, designated integrative hallmarks, arise when cellular damage 
is not efficiently compensated and eventually affect tissue homeostasis leading to the 
functional decline associated with ageing. Since the above mentioned hallmarks are 
interconnected and occur simultaneously during ageing, the exact hierarchic relation 
between them is yet to be determined. 
Independently of their specific contribution to ageing, all these hallmarks consist of 
stressful conditions that will eventually damage cells and tissues. Therefore, understanding 
the complex biological processes linking ageing and stress will facilitate future 
interventions to circumvent age-related functional deterioration and improve human 
healthspan. 
Figure 1: Hallmarks of Ageing. The proposed nine hallmarks of ageing are grouped into three 
categories: the primary hallmarks, which are considered to be the initiating causes of cellular 
damage; the antagonistic hallmarks that consist in compensatory responses that initially attenuate 
the damage but, when the damage persists, become deleterious; and the integrative hallmarks that 
are the major culprits of age-related functional decline. (Adapted from López-Ótin et al., 2013) 
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2. AGEING AND STRESS
2.1. FREE RADICAL THEORY OF AGEING 
Several different theories exist aiming at explaining the biological process of ageing. 
Among them, the most prominent and experimentally tested is the free radical theory of 
ageing (FRTA), proposed more than 50 years ago by Denham Harman, who stated that 
ageing results from the progressive accumulation of cellular damage caused by reactive 
oxygen species (ROS) generated during normal cellular function (Harman, 1956). Later on, 
in 1972, Harman renamed the theory as mitochondrial free radical theory of ageing 
(MFRTA), after he recognized that mitochondria were the main source and target of ROS 
(Harman, 1972). Ever since, the involvement of mitochondria in the ageing process has been 
widely investigated and reviewed (Sastre et al., 2003, Gomez-Cabrera et al., 2012, Bratic and 
Larsson, 2013). Actually, there are numerous age-associated evidences in favour of the 
MFRTA. For example, several mitochondrial functions decline with ageing, as both the 
efficiency of electron transport through the respiratory chain and the activity of 
mitochondrial ROS scavenging enzymes decreases. In contrast, ROS generation increases 
and the incidence of mitochondrial DNA damage rises (Shigenaga et al., 1994, Castro et al., 
2012, Sastre et al., 2002). In further support to the involvement of mitochondrial ROS in 
ageing, it was shown that the microinjection of aged mitochondria in young fibroblast 
resulted in the rapid acquisition of aged properties (Corbisier and Remacle, 1990). 
Interestingly, a higher rate of mitochondrial ROS production is observed in short-lived 
species, when compared to long-lived ones (Perez-Campo et al., 1998).  
Nowadays, it is consensual that the occurrence and accumulation of oxidatively 
damaged biomolecules are implicated in age-associated functional deterioration of cells and 
tissues. The main contributors for this process are the increased levels of ROS and the 
reduced efficiency of the antioxidant protective mechanisms that usually associates with 
ageing. 
2.2. OXIDATIVE STRESS 
Oxidative stress was first defined as a condition characterized by an imbalance 
between the intracellular levels of ROS and the cellular antioxidant capacity, either by an 
increase in pro-oxidants formation or a decrease in antioxidant defences (Sies, 1985). 
Meanwhile, the perception that oxidation-reduction (redox) reactions promoted by ROS are 
fundamental for several biologic signalling pathways led to the redefinition of oxidative 
stress in order to include the role of redox signalling (Jones, 2006). Nowadays, oxidative 
stress is described as “an imbalance between oxidants and antioxidants in favour of the 
oxidants, leading to a disruption of redox signalling and control and/or molecular damage” 
(Sies and Jones, 2007, Sies, 2015). 
INTRODUCTION
29
ROS designate a group of highly reactive molecules that comprises oxygen-centred 
free radicals (i.e. species capable of independent existence that have at least one unpaired 
valence electron) such as hydroxyl radical (HO.) and superoxide anion (O2.-), but also 
includes some oxygen derived non-radicals as hydrogen peroxide (H2O2). The reactivity of 
these species is variable, but HO. is the most reactive as upon its in vivo generation, it reacts 
immediately at the formation site (Halliwell and Cross, 1994). Under aerobic physiological 
conditions, mitochondrial generation of O2.- and H2O2 constitutes the major intracellular 
source of ROS (as reviewed in: Cadenas and Davies, 2000). O2.- is formed by the partial 
reduction of molecular oxygen (O2) caused by electrons that accidentally leak from the inner 
mitochondrial membrane respiratory chain (Barja and Herrero, 1998). It was stated that 
about 2 % of the molecular oxygen utilized by mitochondria would originate O2.- (Chance et 
al., 1979) but this value was considered overestimated; it is now believed that the O2 
fraction leading to O2.- generation is 0,15 % (St-Pierre et al., 2002). Another quantitatively 
large mitochondrial source of ROS is the outer membrane bound monoamine oxidases 
(MAOs), whose function is to catalyse the oxidative deamination of biogenic amines using 
O2 as an electron acceptor forming H2O2 (Edmondson, 2014).  
The deleterious effects that can result from ROS action can be prevented by several 
antioxidant mechanisms. Manganese superoxide dismutase (MnSOD), a mitochondrial 
matrix enzyme, readily neutralizes O2.- by converting it into O2 and H2O2 (Weisiger and 
Fridovich, 1973). In turn, in the mitochondrial intermembrane space, O2.- level is controlled 
either by conversion to O2 upon cytochrome c reduction, or by enzymatic dismutation 
catalysed by a copper and zinc containing superoxide dismutase (CuZnSOD), which is also 
present in the cytoplasm of eukaryotic cells (Okado-Matsumoto and Fridovich, 2001). The 
action of SOD enzymes further increases H2O2 levels both in mitochondria and cytoplasm.  
To protect biomolecules from consequent oxidative damage, cells contain 
glutathione peroxidases and catalase enzymes whose function is to keep H2O2 levels low 
(Sies, 2014). However, the existence of high levels of H2O2 in the presence of reduced redox 
active metal ions, such as Fe (II) or Cu(I), may originate the much reactive hydroxyl radical 
(HO.) by Fenton reaction (Figure 2) (Kehrer, 2000), that readily reacts at its site of 
production and attacks whichever biomolecule it encounters to initiate free radical chain 
reactions (Halliwell and Gutteridge, 2007). In fact, HO. is able to oxidatively damage DNA, 
lipids and proteins and affect their functions, which eventually impact on cell and tissue 
integrity (Halliwell and Cross, 1994).  
Figure 2: Fenton reaction. In the presence of reduced redox active metals, such as Fe(II) or Cu(I), 
hydrogen peroxide (H2O2) is decomposed and originate the extremely reactive hydroxyl radical (HO.) 
that may oxidize biomolecules, such as proteins, lipids and DNA, and affect their functions. 
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2.3. ENDOPLASMIC RETICULUM STRESS 
As a result of the age-related increase in ROS generation, there is a progressive 
accumulation of oxidatively damaged proteins within cells and tissues (Levine and 
Stadtman, 2001). To repair or eliminate such altered proteins and avoid cell dysfunction, 
cells activate quality control chaperoning and degradation mechanisms. But, then again, the 
efficiency of these protective cellular responses is decreased with ageing (Hayashi and Goto, 
1998, Petropoulos et al., 2000, Soti and Csermely, 2000, Viteri et al., 2004). Altogether, the 
age-related impairment of protein quality control mechanisms and the accumulation of 
altered damaged proteins are the major culprits for the occurrence of proteostasis 
disruption during ageing and frequently correlate with age-associated diseases. Actually, it 
is well established that protein misfolding, accumulation and aggregation are well known 
contributors to the pathogenesis of several age-associated disorders, such as Alzheimer and 
Parkinson neurodegenerative diseases (Kopito and Ron, 2000, Selkoe, 2003), adding 
further relevance to the study of the molecular mechanisms behind the loss of proteostasis 
during the ageing process. 
Eukaryotic cells possess an important protein quality control mechanism located 
within the endoplasmic reticulum (ER), which has been shown to play a crucial role in 
maintaining cellular proteostasis (as reviewed in: Noack et al., 2014). The ER is an organelle 
composed of a vast network of interconnected membranous cisternae with a continuous 
intraluminal space that extends throughout the cytoplasm of eukaryotic cells. Its structural 
organization is highly dynamic as it can assume multiple configurations that allow the 
performance of different functions in distinct regions within the cell (Voeltz et al., 2002). 
The ER can be morphologically and functionally divided in two major regions, the smooth 
(SER) and the rough endoplasmic reticulum (RER). RER is composed of flattened sacks with 
membrane-bound ribosomes whose main function is the synthesis of proteins to be 
targeted mainly to the cytoplasmic membrane, the extracellular space, the lysosomes, the 
ER and the Golgi complex. In turn, SER consists of an interconnected meshwork of tubules, 
free of ribosomes, which are responsible for the biosynthesis of sterols and phospholipids. 
Moreover, the ER is also the main site for the storage of intracellular calcium ions and play 
an essential role in many cellular signalling processes (Berridge, 2002). The relative amount 
of RER and SER found within different cell types depends on their main functions. For 
instance, RER is much more abundant in protein secreting cells, while steroid-synthesizing 
cells exhibit a higher extension of SER. 
RER-synthesised proteins constitute a significant fraction of the overall cellular 
proteome. In order to maintain cellular functions, it is essential to the ER to assure that only 
correctly folded and functional proteins are able to reach their final destinations. Such 
quality control depend on the fine regulation of molecular chaperones and folding enzymes 
that exist within the ER (Hammond and Helenius, 1995). One of the first molecular 
chaperones encountered by newly ER synthesized polypeptides is the immunoglobulin 
binding protein (BiP), a member of HSP70 family, whose levels are adjusted according to 
the cellular needs. In fact, besides being crucial to promote the correct folding of nascent 
INTRODUCTION
31
proteins, BiP is also recruited by misfolded proteins in an attempt to refold, avoid protein 
aggregation and prevent cellular damage (Haas, 1994). Another chaperone whose activity 
is fundamental for protein homeostasis is calnexin, an ER transmembrane lectin that 
controls the quality of newly synthesized glycoproteins (Hammond et al., 1994). A critical 
step for most ER-synthesized proteins to acquire their native conformation is the formation 
of disulphide bonds. This process involves thiol-disulphide oxidation, reduction and 
isomerisation and is catalysed by protein disulphide isomerase (PDI) in the optimal 
oxidizing environment of the ER, which is maintained by ER oxireductin-1 (Ero1; Ellgaard 
and Ruddock, 2005).  
The occurrence of stress that compromises ER function is likely to impair protein 
folding and maturation processes and lead to the accumulation of unfolded and misfolded 
proteins in the lumen of the organelle, a condition termed ER stress. The ER responds to 
such proteostasis disruption by activating the ER stress response or unfolded protein 
response (UPR; Schroder and Kaufman, 2005). The UPR is an adaptive coordinated 
response that can be triggered by three ER transmembrane transducers: inositol-requiring 
enzyme-1 (IRE1), pancreatic ER kinase -like ER kinase (PERK) and activating transcription 
factor-6 (ATF6). The activation of these pathways aims to increase ER folding ability, to 
reduce global protein translation (Harding et al., 1999) and, when necessary, to enhance 
ER-associated proteasome degradation (ERAD) of misfolded proteins (Friedlander et al., 
2000). In baseline conditions, IRE1, PERK and ATF6 activities are inhibited by the binding 
of BiP to their luminal domains. However, in the presence of ER stress and misfolded protein 
accumulation, BiP is unbound from the ER transducers, which leads to their activation in 
order to prevent protein aggregation (Figure 3). 
IRE1 protein contains an N-terminal portion located in the ER lumen, a single 
transmembrane segment and a C-terminal cytosolic region with a Ser/Thr kinase and an 
endoribonuclease (RNase) domain (Tirasophon et al., 1998). Upon BiP unbinding, IRE1 is 
activated by oligomerization and trans-autophosphorylation of the cytosolic domains. 
Activated RNase domain of IRE1 is able to remove a 26-nucleotide intron from the X-box 
binding protein 1 (XBP1) mRNA, generating a more stable XBP1 spliced variant (XBP1s) 
that, upon translation, acts as a transcription factor that is able to promote the expression 
of several genes involved in maintaining ER homeostasis (Lee et al., 2003). IRE1 RNase 
activity is also capable to degrade a pool of mRNAs that generally encode proteins from the 
secretory pathway through a process designated regulated IRE1-dependent decay of mRNA 
(RIDD; Hollien and Weissman, 2006), reducing the load of ER client proteins. In turn, the 
activated kinase domain of IRE1 phosphorylates c-Jun N-terminal kinase (JNK) through the 
interaction with the adaptor protein tumour necrosis factor (TNF) receptor-associated 
factor 2 (TRAF2; Urano et al., 2000). Then, activated JNK is able to regulate downstream 
effectors either towards apoptosis (Szegezdi et al., 2006) or cell survival (Ogata et al., 2006). 
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Figure 3: Endoplasmic reticulum unfolded protein response. In baseline conditions, BiP 
chaperone is bound to three ER transmembrane sensors: IRE1, PERK and ATF6. In ER stress 
conditions, unfolded and misfolded proteins accumulate within the organelle and recruit BiP to aid 
in their refolding and prevent their aggregation. Upon BiP unbinding, the ER sensors are activated 
and initiate the unfolded protein response (UPR) that aims at alleviating ER stress and restoring ER 
homeostasis. IRE1-mediated UPR (in blue) is initiated by IRE1 oligomerization and activation by 
phosphorylation. Once activated, IRE1 kinase domain indirectly leads to JNK phosphorylation, which 
is then able to regulate downstream effectors either towards apoptosis or cell survival. On the other 
hand, IRE1 ribonuclease activity promotes the removal of a 26-nucleotide intron from XBP1, 
originating the spliced variant XBP1s that, upon translation, acts as a transcription factor that 
promotes the expression of genes involved in maintaining ER homeostasis. Similarly to IRE1, PERK 
activation also depends on its oligomerization and phosphorylation (in green). Upon activation, PERK 
phosphorylates eIF2, which causes the inhibition of general protein translation in an attempt to 
reduce ER protein load. In addition, phospho-eIF2 allows the selective translation of ATF4, which is 
a transcription factor that regulates the expression of genes involved in amino-acid metabolism and 
stress response aiming at increasing cell resistance to stress and ameliorating ER stress. ATF4 also 
promotes the expression of the transcription factor CHOP that at initial stages mediates a pro-
survival response by upregulating autophagy-related genes, but as stress is prolonged, regulates pro-
apoptotic target genes leading to cell death. Finally, ATF6-mediated UPR (in red) is initiated by ATF6 
translocation to the Golgi compartment upon BiP dissociation. There, ATF6 is submitted to 
proteolytic cleavage by cytosolic proteases and releases a 50kDa cytosolic fragment, the ATF6(p50), 
that becomes an active transcription factor, able to regulate the expression XBP1, CHOP, ER 
chaperones and folding enzymes in order to restore ER proteostasis. 
Similarly to IRE1, PERK protein contains a Ser/Thr kinase domain in its cytosolic C-
terminal, and its activation involves dimerization and trans-autophosphorylation upon BiP 
release from its N-terminal domain in the ER lumen (Bertolotti et al., 2000). Activated PERK 
phosphorylates the eukaryotic translation initiation factor 2 α (eIF2α), which results in the 
inhibition of global protein synthesis and consequently in the reduction of protein load into 
the ER (Harding et al., 2000). Also, phosphorylated eIF2α allows the selective translation of 
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activating transcription factor-4 (ATF4), which is able to regulate the expression of several 
genes involved in amino-acid metabolism, stress response and protein secretion, aiming at 
alleviating ER stress and increase cell resistance to stress (Harding et al., 2003). Besides, 
ATF4 can also promote the expression of C/EBP-homologous protein (CHOP), a 
transcription factor that is classically known as being able to upregulate pro-apoptotic 
genes leading to ER stress-induced apoptotic cell death (Zinszner et al., 1998). However, 
CHOP was additionally described as having differential effects depending on the duration of 
stress: at an initial stage it mediated a protective pro-survival response by upregulating 
autophagy-related genes, but as stress was prolonged, CHOP limited autophagy and 
promoted apoptosis through the transcriptional control of specific target genes (B'chir et 
al., 2014). 
Finally, ATF6 is an ER transmembrane protein that contains a DNA binding motif in 
its cytosolic N-terminal portion. In ER stress conditions, BiP dissociates from the C-terminal 
domain of ATF6 located in the ER lumen and allows ATF6 translocation to the Golgi 
compartment. There it is submitted to proteolytic cleavage by site 1 and site 2 proteases 
and releases a 50kDa cytosolic fragment (ATF6(p50)) that becomes an active transcription 
factor, able to migrate to the nucleus and promote the expression of XBP1, CHOP, ER 
chaperones and folding enzymes, in an attempt to restore ER proteostasis (Yoshida et al., 
2000).  
The activation of the UPR usually leads to an increase of cellular tolerance to higher 
amounts of abnormal ER proteins by folding promotion. However, when proteins fail to 
properly fold and assembly to achieve their functional conformation, the UPR chaperone 
system acts in coordination with the ERAD degradative machinery to eliminate misfolded 
proteins preventing the occurrence of damage (Friedlander et al., 2000). Furthermore, 
ERAD also plays an important role in the regulation of ER resident proteins levels according 
to the cellular needs. ERAD is thus a complex process through which either abnormal or no 
longer needed ER proteins are targeted and ultimately degraded by the cytosolic ubiquitin-
proteasome system. This occurs in four main steps, which are: substrate selection, 
dislocation across the ER membrane to the cytosol, poly-ubiquitination and proteasomal 
degradation (Olzmann et al., 2013).  
During ageing, the efficiency of UPR seems to be compromised, as shown by age-
related alterations of ER molecular chaperones and folding enzymes expression (as 
reviewed in: Naidoo, 2009). Several studies provided evidence that BiP (Paz Gavilan et al., 
2006, Erickson et al., 2006, Hussain and Ramaiah, 2007, Naidoo et al., 2008), calnexin (Paz 
Gavilan et al., 2006, Erickson et al., 2006) and PDI (Paz Gavilan et al., 2006) protein levels 
decrease with ageing in rodent tissues. In addition, both BiP and PDI were found to be 
oxidized (Rabek et al., 2003) and consequently became less functional (Nuss et al., 2008) in 
aged mice livers, indicating that ER proteins are vulnerable to the increased oxidative stress 
that accompanies ageing. Besides the alterations on ER lumen proteins, PERK-mediated 
UPR pathway was also reported to be affected during ageing, as PERK mRNA was found 
decreased in the hippocampus of aged rats (Paz Gavilan et al., 2006) and eIF2α 
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phosphorylation was lower in several tissues from aged rats, when compared to young 
animals (Hussain and Ramaiah, 2007). The UPR has also been implicated in the 
pathogenesis of a variety of age-associated diseases, such as type II diabetes, atherosclerosis 
and neurodegenerative disorders (as reviewed in: Brown and Naidoo, 2012).  
So, accumulated evidence shows UPR activation involvement in the ageing process, 
but its actual contribution to the cellular and molecular changes that accompany cellular 
ageing remain unclear.  
3. CELLULAR SENESCENCE
3.1. THE ROLE OF SENESCENT CELLS IN ORGANISMAL AGEING 
At the cellular level, the occurrence of ageing is usually termed cellular senescence 
and is characterized by the appearance of typical morphological and molecular alterations 
that affect cellular function. The actual existence of senescent cells in living organisms had 
been extensively debated (Ben-Porath and Weinberg, 2004) mainly due to two major 
limitations. First, most cells in organismal tissues are post-mitotic, which led researchers to 
question whether such cells, similarly to proliferating ones, could also become senescent; 
the second limitation was the lack of markers able to exclusive and unequivocally detect the 
senescent cells. Therefore, to circumvent the general lack of specificity of such senescence 
biomarkers, they are often used in combination, which apart from allowing the 
identification of senescent cells also provide further clues on the mechanisms behind their 
appearance. The histochemical detection of senescence associated β-galactosidase (SA 
βgal), a lysosomal enzyme whose activity is increased in senescent cells, was the first and is 
the most widely used marker of senescence (Dimri et al., 1995, Pendergrass et al., 1999, 
Paradis et al., 2001, Ding et al., 2001, Geng et al., 2010). However, its use has been 
questioned as it was also identified in non-senescent cells (Yegorov et al., 1998, Severino et 
al., 2000, Yang and Hu, 2005). The search for the perfect senescence biomarker is still a 
matter of intensive research, which, nevertheless, revealed many strong candidates. These 
include genes involved in the establishment and maintenance of senescence, as p21 (Ding 
et al., 2001) and p16 (Janzen et al., 2006, Krishnamurthy et al., 2006, Molofsky et al., 2006, 
Ressler et al., 2006); genotoxic stress markers located at the telomeres, as p53 binding 
protein 1 (Herbig et al., 2006, Jeyapalan et al., 2007) or phosphorylated histone H2AX (Wang 
et al., 2009); and distinctive and highly dense nuclear regions, the senescence-associated 
heterochromatin foci (SAHF; Jeyapalan et al., 2007, Kreiling et al., 2011). 
Nevertheless, in the last two decades, the use of the above mentioned senescence 
markers allowed researchers to demonstrate that the abundance of senescent cells increase 
in multiple tissues from rodents and primates (including humans) along chronological 
ageing and in age-associated pathologies, suggesting that these cells might play a role in the 
typical age-related functional involution (as reviewed in: Burton and Krizhanovsky, 2014). 
In aged mice, senescent cells were detected in diverse tissues and organs, such as brain 
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(Molofsky et al., 2006, Jurk et al., 2012), pancreas (Krishnamurthy et al., 2006), skeletal 
muscle (Kreiling et al., 2011), bone marrow (Janzen et al., 2006), lung (Wang et al., 2009, 
Kreiling et al., 2011), liver (Wang et al., 2009, Kreiling et al., 2011, Hewitt et al., 2012), 
adipose tissue (Tchkonia et al., 2010), small intestine (Wang et al., 2009, Hewitt et al., 2012), 
spleen and skin (Wang et al., 2009). In addition, using aged rats, the occurrence of cellular 
senescence was also described in a specific hippocampus region (Geng et al., 2010) and in 
kidney (Ding et al., 2001). Only a few studies employed tissues from aged primates. More 
than fifteen years ago it was shown that the frequency of senescent cells was increased in 
liver biopsies from aged monkeys (Pendergrass et al., 1999). Moreover, studies using skin 
and muscle biopsies from aged baboons also reported increased number of senescent cells 
when compared to young animals tissues (Herbig et al., 2006, Jeyapalan et al., 2007, Kreiling 
et al., 2011). In humans, despite the inherent difficulties in obtaining human samples, 
cellular senescence in vivo was described in skin (Dimri et al., 1995, Ressler et al., 2006) and 
liver (Paradis et al., 2001) samples from aged individuals. Furthermore, an increased 
incidence of senescent cells was reported in tissues of patients with age-associated 
disorders, such as atherosclerosis (Minamino et al., 2002, Gorgoulis et al., 2005, 
Erusalimsky, 2009), type II diabetes (Sone and Kagawa, 2005, Markowski et al., 2013), 
osteoporosis (Benisch et al., 2012), cataracts (Babizhayev et al., 2011) and Alzheimer 
disease (Malavolta et al., 2013).  
The identification of senescent cells in tissues predominantly composed of post-
mitotic cells proved that, similarly to proliferating cells, mature post-mitotic cells are also 
able to develop a senescent phenotype in situ, even though the underlying mechanisms may 
be different. Despite the usually low frequencies reported, the gradual accumulation of 
senescent cells within tissues appears to reflect the existence of a general cellular response 
to stress. As a state of permanent inhibition of cell proliferation, senescence was pointed 
out as an appealing tumour suppressive cellular mechanism, thus able to prevent the 
development of malignancies (Campisi, 1996). 
Paradoxically, it was later shown that senescent cells promoted the growth of 
premalignant cells by altering cellular neighbourhood (Krtolica et al., 2001, Liu and 
Hornsby, 2007). In fact, senescent cells are not passive bystanders within tissues, as they 
remain metabolically active and profoundly affect the surrounding environment through 
the secretion of factors that collectively constitute the senescent-associated secretory 
phenotype (SASP; Coppe et al., 2008). The SASP mainly consists of pro-inflammatory 
cytokines, growth factors and matrix metalloproteinases (Kuilman and Peeper, 2009) that 
act either in an autocrine or a paracrine fashion. Actually, the secretion of chemokines and 
growth factor binding proteins by senescent cells was able to further reinforce the 
senescent phenotype within the secreting cells (Acosta et al., 2008, Kuilman et al., 2008, 
Wajapeyee et al., 2008). Besides, the SASP can also exert either beneficial or detrimental 
paracrine actions depending on the context. In younger individuals, a localized and time-
limited pro-inflammatory SASP is crucial to alert nearby cells to potential danger and to 
promote immune clearance of damaged senescent cells, thus avoiding tissue injury and 
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dysfunction (Xue et al., 2007, Krizhanovsky et al., 2008, Kang et al., 2011). However, during 
ageing, the effectiveness of the immune system is reduced and, as it becomes less competent 
to clear senescent cells, their age-related accumulation ensues.  Therefore, in older 
individuals, the presence of a pronounced and persistent SASP causes chronic inflammation, 
and negatively affects the surrounding environment by disrupting tissue structure and 
organization (Parrinello et al., 2005), by stimulating tumourigenesis of nearby pre-
malignant cells (Krtolica et al., 2001, Coppe et al., 2008) or by inducing senescence in normal 
neighbour cells (Hubackova et al., 2012, Acosta et al., 2013). 
There is a vast amount of data relating the deleterious effects of the SASP from 
senescent cells in vivo to age-associated tissue degeneration and organ dysfunction. 
However, the first direct evidence for a causal link between the existence of senescent cells 
and the development of age-related pathologies was demonstrated using a mouse model 
where the elimination of p16-positive senescent cells prevented or delayed tissue 
dysfunction and extended healthspan (Baker et al., 2011). Then, using a similar 
experimental approach, it was demonstrated a positive role of senescent cells and their 
SASP in tissue repair and regeneration because the removal of p16-positive senescent cells 
in vivo resulted in delayed skin wound healing (Demaria et al., 2014). These distinct roles of 
cellular senescence in vivo, either as a tissue remodelling aiding mechanism or a noxious 
chronic inflammatory source, encourage further investigation aiming at developing 
potential therapeutic tools to enhance or block senescence, depending on the context. The 
best experimental approach to unravel the detailed mechanisms behind human cellular 
senescence is to use in vitro cellular models as they are easy to obtain and manipulate. 
3.2. IN VITRO CELLULAR MODELS 
REPLICATIVE SENESCENCE 
In 1965, Leonard Hayflick observed that serially cultivated human diploid 
fibroblasts (HDFs) exhibited a limited proliferative potential and became irreversibly 
arrested after a finite  number of population doublings (PDs), even in the presence of 
mitogens (Hayflick, 1965). Such condition was considered a manifestation of ageing at a 
cellular level, and was designated cellular senescence or replicative senescence (RS). Since 
then, in vitro models of dividing somatic cells, including fibroblasts (Hayflick, 1965), 
endothelial cells (Mueller et al., 1980), vascular smooth muscle cells (Bierman, 1978), 
keratinocytes (Rheinwald and Green, 1975) and lymphocytes (Tice et al., 1979), have been 
preferred systems utilized by researchers to unravel the complex molecular mechanisms 
and pathways underlying the human ageing process. 
Upon the early observations, it was noticed that the number of doublings of a cell 
population in culture before attaining RS was fairly reproducible, which indicated the 
existence of a cell division counting mechanism. Telomeres could function as sensors for 
such mechanism, as they were found to shorten as cells age (Harley et al., 1990) and when 
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they reached a critical minimum size, a cell cycle inhibition response was triggered leading 
to cellular senescence. Actually, the ectopic expression of telomerase, a specialized enzyme 
able to compensate telomeric DNA losses, was found sufficient to revert RS cells into a 
phenotypically youthful state (Bodnar et al., 1998). 
Telomere attrition is unlikely to be solely a cell division counting mechanism as it 
was shown that a given cell population in culture exhibit a large heterogeneity in telomere 
length both within individual cells and between cells (Lansdorp et al., 1996, Baird et al., 
2003, Zou et al., 2004). One explanation for such heterogeneity is the occurrence of telomere 
damage caused by oxidative stress (Sozou and Kirkwood, 2001). Being so, the lifespan of an 
individual cell population is not only dependent on telomere length but is also affected by 
external stochastic factors upstream of telomere shortening (Passos et al., 2007). 
Whichever the cause for telomere attrition, this event will activate a DNA damage response 
that culminates in a G1 phase cell cycle arrest (Huang et al., 1996, Saretzki et al., 1999). 
Even though the major hallmarks of RS are the cell cycle arrest and the insensitivity 
to mitogens, RS cells also exhibit other typical structural and functional changes that are 
collectively designated as the senescent phenotype. When compared to young proliferating 
cells, RS fibroblasts experience dramatic morphological alterations that include the increase 
in cell surface area and volume (Greenberg et al., 1977), the loss of typical small spindle-
fusiform shape and the acquisition of large, flat, morphology (Nishio et al., 2001). In 
addition, senescent cells also undergo several organellar changes. Their lysosomes increase 
in number and size (Lipetz and Cristofalo, 1972) and accumulate granules of lipofuscin 
(Brunk and Terman, 2002), the so-called “age-pigment” that is essentially composed of 
oxidized material (proteins, lipids and, in a lesser amount, carbohydrates) and transition 
metals (Benavides et al., 2002, Double et al., 2008). 
In part, as a consequence of the rise in lysosomal content, RS cells exhibit an 
increased amount of SA βgal (Dimri et al., 1995). Regarding mitochondria, although they 
exist in higher number in RS cells (Lee et al., 2002), they are oxidatively affected (Mecocci 
et al., 1993, Ahmed et al., 2010) and less functional (Boffoli et al., 1994). Moreover, when 
compared to actively proliferating cells, senescent cells exhibit larger nuclei (Mitsui and 
Schneider, 1976) where they show highly condensed regions, the SAHF. Such regions seem 
to relate to transcriptionally suppressed E2F-responsive genes, thus contributing to cell 
cycle arrest (Narita et al., 2003). 
In fact, RS cells present an altered gene expression profile that differ depending on 
cell type (Shelton et al., 1999). Many of the altered genes are involved in a diversity of 
processes such as cell cycle regulation, inflammation and immune response, cytoskeleton 
organization, stress response and metabolism (Zhang et al., 2003, Ly et al., 2000, Yoon et al., 
2004). Some genes and their respective proteins are overexpressed and their assessment 
has been used to evidence cellular senescence; they include apolipoprotein J (ApoJ), 
fibronectin, osteonectin, transforming growth factor β-1 (TGFβ1) and insulin growth factor 
binding protein 3 (IGFBP3) (Debacq-Chainiaux et al., 2008). In addition, overexpression of 
genes encoding the cyclin dependent kinase inhibitors (CDKIs) p21 and p16 is also typical 
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for RS cells and leads to an irreversible cell cycle arrest in G1 phase (Alcorta et al., 1996, 
Pignolo et al., 1998). Moreover, the cytoskeleton -actin and vimentin proteins were also 
reported to be differentially expressed in RS cells (Trougakos et al., 2006). 
In general, RS cells are resistant to apoptosis, although this effect may depend on the 
cell type and the pro-apoptotic signal. For instance, RS endothelial cells, but not fibroblasts, 
are susceptible to ceramide-induced apoptosis (Hampel et al., 2004). In addition, RS 
fibroblasts resist to growth factor deprivation- and oxidative stress-induced cell death but 
not Fas-mediated apoptosis (Chen et al., 2000a, Tepper et al., 2000). The mechanism behind 
senescence-associated apoptosis resistance is not clear, but the up-regulation of genes 
encoding survivin (Al-Khalaf and Aboussekhra, 2013), c-myb (Lee et al., 2010), major vault 
protein (Ryu et al., 2008) and bcl-2 (Ryu et al., 2007) have already been implicated. In 
addition, epigenetic mechanisms able to regulate bcl-2:bax gene expression in RS 
fibroblasts, were proposed to contribute to the apoptosis-resistant phenotype (Sanders et 
al., 2013). 
PREMATURE SENESCENCE 
Allowing cells to reach their proliferative limit in culture is not the only way to 
obtain senescent cells, because cellular senescence can be experimentally induced either by 
oxidative stress or oncogene activation. In fact, it was suggested that non-tumour cells 
present mechanisms that override the proliferative activity of oncogenes by promoting 
senescence (Serrano et al., 1997). Since then, several oncogenes were described as capable 
to trigger oncogene-induced senescence (OIS), including H-RasG12V (Serrano et al., 1997), 
BRAFV600E (Michaloglou et al., 2005) and NF-B (Bernard et al., 2004). The obvious 
limitations of the in vitro studies, consequent to inherent differences between in vivo and in 
vitro microenvironments, initially brought some confusion and scepticism on the potential 
role of OIS in vivo (Sherr and Depinho, 2000). However, later, animal model studies or intact 
human tissues provided substantial evidence in favour of the occurrence of OIS as a 
physiologic protective mechanism against cancer (Braig et al., 2005, Michaloglou et al., 
2005, Lazzerini Denchi et al., 2005). 
Alternatively, premature senescence can be induced by oxidative stress, a condition 
named stress-induced premature senescence (SIPS). Actually, cellular models of SIPS are 
the most frequently used to study the molecular mechanisms underlying the ageing process. 
They are established upon exposure of actively dividing cells to subcytotoxic doses of 
oxidative stress inducers, such as hydrogen peroxide (H2O2) (Chen and Ames, 1994), tert-
butyl hydroperoxide (tBHP) (Dumont et al., 2000), hyperoxia (Saretzki et al., 1998) or ultra-
violet B radiation (UVB) (Debacq-Chainlaux et al., 2005), among others. Similarly to RS, SIPS 
model exhibits an irreversible cell cycle arrest in the G1 phase (Chen et al., 1998, Von 
Zglinicki et al., 1995) and the senescent phenotype typical structural and molecular 
features; therefore, it is an excellent model for the study of cellular senescence.  
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The most widely utilized SIPS model is obtained by exposing early passage 
fibroblasts to a subcytotoxic concentration of H2O2 for 2h (H2O2-SIPS). After a three-day 
period of recovery, most treated cells cease to proliferate and exhibit a senescent-like 
morphology. Moreover, they present an increased SA βgal activity and altered gene and 
protein expression profiles, resembling RS cells (Chen and Ames, 1994, Chen et al., 1998, 
Chen et al., 2000b). In fact, similarly to RS fibroblasts, hyperoxia- (Saretzki et al., 1998), 
tBHP- or H2O2-SIPS (Dumont et al., 2000) cells exhibit overexpression of several 
senescence-associated genes, as p21, ApoJ, fibronectin, IGFBP3 and TGFβ1. In addition, 
using the H2O2-SIPS model, it was demonstrated that TGFβ1 overexpression is required to 
promote the typical senescent morphological changes, the increased activity of SA βgal and 
the overexpression of fibronectin, ApoJ and osteonectin (Frippiat et al., 2001). 
Still, RS and SIPS are not the same and some differences were described. For 
example, the involvement of telomere attrition in the establishment of SIPS is controversial. 
While some studies demonstrated that in hyperoxia- or H2O2-SIPS cells, telomeres shorten 
faster than in young fibroblasts (Von Zglinicki et al., 1995, Duan et al., 2005), others failed 
to show that and suggested that SIPS can be induced without telomere shortening (Chen et 
al., 2001). Such conflicting evidence may result from experimental variations regarding the 
type and intensity of the oxidative stress inducer used in the different studies. However, 
despite these controversial facts, telomere attrition seems to be affected by oxidative stress 
as cell culture supplementation with antioxidants showed to be efficient in slowing 
telomere shortening (Furumoto et al., 1998, Von Zglinicki et al., 2000). Moreover, in SIPS 
cells, telomeres were found to sense the presence of oxidative stress, accumulate damage in 
their DNA and activate a cellular response that resulted in the inhibition of cell proliferation 
through p21 overexpression (Saretzki et al., 1999). Furthermore, comparative proteomic 
studies using SIPS and RS cells showed that each condition has its own protein expression 
pattern, although they exhibit the same, typical, senescent phenotype (Dierick et al., 2002, 
Aan et al., 2013). This indicates that different pathways may be involved, but all seem to 
converge at the senescent phenotype. 
One major advantage of using SIPS models is the fact that the induction of 
senescence can be studied independently from purely adaptive responses; indeed, SIPS 
induction protocols include a cell recovery period of at least three days after stress, before 
the analysis of the senescent biomarkers. Another important point is that after exposure to 
stress, either acute or chronic, there is not an all-or-none response of cells. In fact, a single 
acute exposure to a stress inducer inhibits proliferation of a fraction of cells whereas the 
other fraction remains unharmed and able to continue proliferating. Such heterogeneous 
cellular response makes SIPS an ideal model to study cellular senescence, as a similar 
response is observed at the organismal level during ageing. Besides, these in vitro cellular 
models of senescence are also a valuable tool in the search for compounds with the potential 
to modulate ageing progression. Such research might result in the discovery of specific 
targets that ultimately may be modulated to delay or attenuate age-related functional 
deterioration and the establishment or progression of age-associated diseases. 
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3.3. ATTENUATION OF CELLULAR SENESCENCE 
So far, caloric restriction (CR) has been described as the best strategy to increase 
lifespan in a variety of organisms, including yeast, worms, flies, fish, mice and rats (as 
reviewed in: Heilbronn and Ravussin, 2003). Furthermore, in mammals, CR induces 
metabolic changes known to improve healthspan and reduces the incidence and delays the 
onset of age-associated disorders (Halagappa et al., 2007, Speakman and Mitchell, 2011). In 
an attempt to explain the anti-ageing effects of CR, a number of studies repeatedly 
demonstrated its ability to promote stress resistance and attenuate the appearance and 
accumulation of oxidative stress induced cellular damage (Matsuo et al., 1993, Sohal et al., 
1994, Dubey et al., 1996, Lee et al., 1999, Hamilton et al., 2001).  
The silent information regulator 2 (Sir2) protein was identified in yeast as a key 
mediator in lifespan extension promoted by CR (Lin et al., 2000). In addition, Sir2 
homologues were shown to contribute to CR-associated anti-ageing effects in flies (Rogina 
and Helfand, 2004), worms (Tissenbaum and Guarente, 2001) and mammals (Chen et al., 
2005). The mammalian orthologue protein of Sir2 is sirtuin 1 (Sirt1), which belongs to a 
family of 7 homologous proteins (Sirt1-7) that are NAD+-dependent deacetylases known to 
regulate molecular pathways involved in energy metabolism, cell survival and longevity (as 
reviewed in: Michan and Sinclair, 2007). Sirt1 substrates include histones (Imai et al., 2000, 
Vaquero et al., 2004), tumour suppressor p53 protein (Vaziri et al., 2001) and the family of 
forkhead box O (FOXO) transcription factors (Brunet et al., 2004).  
During ageing, Sirt1 expression was shown to decrease in tissues from rodents 
(Lafontaine-Lacasse et al., 2010, Jin et al., 2011, Quintas et al., 2012, Gong et al., 2014) and 
humans (Lin et al., 2011, Lu et al., 2014, Thompson et al., 2014). In addition, the enzyme 
activity was diminished in the liver, heart, kidney and lung from aged rats when compared 
to young controls (Braidy et al., 2011). Moreover, Sirt1 expression was reduced in the 
affected human tissues of age-associated disorders, such as cataracts (Lin et al., 2011), 
Huntington (Pallas et al., 2008) and Alzheimer (Julien et al., 2009) diseases. At the cellular 
level, various in vitro models of cellular senescence also exhibit reduced expression of Sirt1 
(Sasaki et al., 2006, Furukawa et al., 2007, Ho et al., 2009, Song et al., 2014). In fact, it was 
experimentally demonstrated that the inhibition of Sirt1 was sufficient to induce cellular 
senescence both in endothelial cells (Ota et al., 2007) and fibroblasts (Volonte et al., 2015), 
while Sirt1 overexpression was able to attenuate senescence and to extend the replicative 
lifespan of different cell types in culture (Ota et al., 2007, Huang et al., 2008, Ho et al., 2009, 
Yamashita et al., 2012). Altogether, these evidences clearly support the beneficial effects of 
Sirt1 in the ageing process both in vivo and in vitro. 
The identification of molecules that could induce or activate Sirt1, thus mimicking 
CR anti-ageing effects, emerged as a promising research area within gerontology. So far, a 
large number of dietary and synthetic compounds were reported to induce Sirt1 activity (as 
reviewed in: Sinclair and Guarente, 2014). Among them, an important part has been ascribed 
to polyphenols that include resveratrol found in red wine grape skins, some berries and 
peanuts. Resveratrol was initially described as a phytoalexin, with antimicrobial activity 
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(Langcake and Pryce, 1976) and attracted more attention after being pointed as responsible 
for the cardioprotective effects of red wine (Siemann and Creasy, 1992). Nowadays, 
resveratrol is known to exert protective effects in various pathological entities, such as 
obesity, diabetes and cardiovascular disease (as reviewed in: Smoliga et al., 2011). 
Moreover, its ability to modulate ageing has been exhaustively tested. Actually, it was shown 
to increase maximum lifespan of a variety of organisms, such as Saccharomyces cerevisiae 
(Howitz et al., 2003), Caenorhabditis elegans  (Wood et al., 2004, Viswanathan et al., 2005), 
Drosophila melanogaster (Wood et al., 2004, Bauer et al., 2004) and the short-lived fish 
Nothobranchius furzeri (Valenzano et al., 2006). However, resveratrol failed to increase 
longevity in rodents, even though it improved their healthspan by exerting protective 
actions against age-related deterioration (Baur et al., 2006, Pearson et al., 2008). Similarly, 
at the cellular level, resveratrol was shown to attenuate senescence in various cell types in 
culture, through the activation of mechanisms that favour increased stress resistance and 
activation of DNA repair mechanisms (Giovannelli et al., 2011, Mikula-Pietrasik et al., 2012), 
induction of telomerase activity (Xia et al., 2008), decreased secretion of senescence-
associated pro-inflammatory proteins (Csiszar et al., 2012), inhibition of the mechanistic 
target of rapamycin, mTOR (Demidenko and Blagosklonny, 2009) and activation of Sirt1-
mediated pathways (Kao et al., 2010, Ido et al., 2015). Furthermore, resveratrol has also 
been considered a promising anti-tumour compound as it was capable to inhibit cell 
proliferation and induce cellular senescence in several tumour cell lines (Fang et al., 2012, 
Yang et al., 2013). 
Despite the large amount of existing data on the effects of resveratrol, the actual 
molecular mechanisms that contribute to its anti-ageing effects are unclear. Thus, 
understanding the molecular dynamics behind the action of this polyphenolic compound 
may allow the identification of specific molecular targets amenable to therapeutic 
modulation aiming at delaying age-associated functional deterioration and improve 
healthspan. 
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4. OBJECTIVES AND STUDY OUTLINE
In vitro cellular models of senescence have been considered essential tools to 
unravel the molecular mechanisms responsible for the typical age-associated cell function 
deterioration (Passos et al., 2009). SIPS models are often used with such purpose, as they 
exhibit several advantages when compared to the original RS cells: they are faster to obtain, 
easier to manipulate and exhibit a heterogeneous cellular response similar to what happens 
in tissues in vivo. The oxidative stress inducer that is most frequently employed to establish 
SIPS is H2O2, but other agents may also be successfully used.  
Aiming at finding a SIPS model that may truthfully reflect the molecular events 
behind the physiological ageing process, it was hypothesized that the redox active metal 
copper would also be capable of inducing SIPS, due to its ability to mediate Fenton reaction 
and promote oxidative stress. Also, several evidences indicate that copper homeostasis is 
disrupted during ageing and therefore may be an important contributor to the ageing 
process. In fact, increased in vivo copper level was repeatedly associated with chronological 
ageing (Harman, 1965, Sohler and Pfeiffer, 1987, Zatta et al., 2008) and age-associated 
entities, such as Parkinson and Alzheimer diseases (Jimenez-Jimenez et al., 1992, Brewer et 
al., 2010). In turn, studies using the fungal ageing model Podospora anserina demonstrated 
delayed cellular ageing in conditions of low intracellular copper, either due to an 
impairment in its cellular uptake (Borghouts et al., 2002) or to the presence of a copper 
chelator (Borghouts et al., 2001). In addition, RS fibroblasts were shown to have increased 
intracellular copper levels when compared to young fibroblasts (Boilan et al., 2013). 
Altogether, these data add further relevance to the development of a copper-induced SIPS 
model, as it could become a valuable tool to evaluate the potential contribution of copper-
induced oxidative stress for age-associated cellular deterioration and to characterize and 
identify the involved molecular processes.  
Therefore, the first goal of the present work was to establish a SIPS model induced 
by copper, using WI-38 human diploid fibroblasts. Following the general study design 
employed in other SIPS models, cells were submitted to subcytotoxic concentrations of 
copper sulfate (CuSO4) for 24h and, upon recovery and adaptation for an additional 72h 
period, they evidenced characteristic features of the senescent phenotype. They included 
the typical senescent morphology, cell proliferation inhibition, increased percentage of SA 
βgal positive cells, and overexpression of several genes and proteins typically associated 
with senescence, such as p21, ApoJ and TGFβ1. These findings demonstrated for the first 
time that CuSO4 was actually able to induce premature senescence in cultivated human 
fibroblasts (Publication I). Next, in the search for underlying mechanisms, it was 
hypothesized that proteostasis disruption, a typical hallmark of ageing, would take place 
and activate compensatory mechanisms as the ER UPR. For its assessment the levels of ER 
resident molecular chaperones and enzymes and the activation of PERK-, IRE1- and ATF6-
mediated UPR pathways were evaluated. Both RS and CuSO4-SIPS models exhibited similar 
results regarding the ER molecular alterations, in contrast to the data obtained for H2O2-
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SIPS fibroblasts. Thereafter, the contribution of UPR activation for the induction of cellular 
senescence was assessed using specific PERK and IRE1 inhibitors. The results showed that 
ER UPR activation was required for the induction of both SIPS models, but, while CuSO4-
induced cell cycle arrest was mediated by PERK activation, this was not verified in H2O2-
SIPS (Publication II). At this point, on account of the molecular mechanisms involved, 
CuSO4-SIPS proved to be more similar to the RS model, compared to the most frequently 
used H2O2-SIPS. 
Finally, a third goal was to test resveratrol ability to modulate the CuSO4-SIPS model 
and unravel additional molecular mechanisms involved. It was demonstrated that the 
polyphenolic compound attenuates the appearance of some typical senescence-associated 
features as SA βgal activity, morphological alterations and cell cycle inhibition. Such anti-
senescence effects, proven to be independent of the regulation of classical senescence-
associated genes and proteins, were shown to improve cellular proteostasis. In fact, CuSO4-
SIPS cells exhibited higher total protein content and increased accumulation of 
carbonylated and poly-ubiquitinated modified proteins (Publication III), thus lending 
additional support to proteostasis disruption in this model as previously suggested 
(Publication II). It is noteworthy that CuSO4-treated cells recovery in the presence of 
resveratrol resulted in improved cellular proteostasis. Moreover, these beneficial effects 
were shown to be associated with the activation of lysosomal autophagy (Publication III). 
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Abstract Human diploid fibroblasts (HDFs) ex-
posed to subcytotoxic concentrations of oxidative
or stressful agents, such as hydrogen peroxide, tert-
butylhydroperoxide, or ethanol, undergo stress-
induced premature senescence (SIPS). This condition is
characterized by the appearance of replicative senes-
cence biomarkers such as irreversible growth arrest,
increase in senescence-associated β-galactosidase (SA
β-gal) activity, altered cell morphology, and overexpres-
sion of several senescence-associated genes. Copper is
an essential trace element known to accumulate with
ageing and to be involved in the pathogenesis of some
age-related disorders. Past studies using either yeast
or human cellular models of ageing provided
evidence in favor of the role of intracellular copper
as a longevity modulator. In the present study,
copper ability to cause the appearance of senescent
features in HDFs was assessed. WI-38 fibroblasts
exposed to a subcytotoxic concentration of copper
sulfate presented inhibition of cell proliferation, cell
enlargement, increased SA β-gal activity, and
mRNA overexpression of several senescence-
associated genes such as p21, apolipoprotein J
(ApoJ), fibronectin, transforming growth factor
β-1 (TGF β1), insulin growth factor binding protein 3,
and heme oxygenase 1. Western blotting results con-
firmed enhanced intracellular p21, ApoJ, and TGFβ1 in
copper-treated cells. Thus, similar to other SIPS-
inducing agents, HDF exposure to subcytotoxic con-
centration of copper results in premature senescence.
Further studies will unravel molecular mechanisms and
the biological meaning of copper-associated senescence
and lead to a better understanding of copper-related
disorder establishment and progression.
Keywords Cellular senescence . Copper .Metals .
Oxidative stress . Human fibroblasts . Ageing
Introduction
Cellular senescence was described more than four
decades ago when it was demonstrated that normal
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cells in culture had a limited ability to proliferate
(Hayflick 1965). It was shown that serially cultivated
human diploid fibroblasts (HDFs) initially exhibit
active cell division, but, after a number of population
doublings, dividing cell number decreases. Eventual-
ly, they cease dividing, become unresponsive to
mitogenic stimuli and enter in a condition termed
replicative senescence (RS). In addition, cells in the
senescent state exhibit dramatic alterations in struc-
ture, mass, and functioning of their subcellular
organelles, when compared with proliferating cells.
They include an enlarged, flat morphology, increased
reactive oxygen species production, lipofuscin accu-
mulation, altered mass and functionality of mitochon-
dria and lysosomes, and enhanced activity of
senescence-associated β-galactosidase (SA β-gal;
Hwang et al. 2009). Moreover, RS cells present
altered expression of several senescence-associated
genes (Debacq-Chainiaux et al. 2008).
A senescent phenotype may be achieved earlier,
when HDFs in vitro are submitted to subcytotoxic doses
of oxidants or other stressful agents such as hydrogen
peroxide (Frippiat et al. 2001), tert-butylhydroperoxide
(t-BHP), ethanol (Dumont et al. 2002), or ultraviolet B
(UVB) radiation (Debacq-Chainiaux et al. 2005).
Experimentally, when such agents are used, immediate
adaptative responses are expected to occur. In order to
circumvent them, the senescent features are assessed
only 2 or 3 days after exposure to the last stress. Cells
in this condition, termed stress-induced premature
senescence (SIPS), remain alive for months and
display many features of RS, including the typical
senescent phenotype, cell cycle arrest, increased
activity of SA β-gal, and gene expression profile
alteration (Toussaint et al. 2000). Since SIPS cells are
able to mimic many of the processes that occur during
RS, they are frequently used to study the mechanisms
of cellular ageing.
In biological systems, copper is an essential trace
element since it acts as a co-factor of different
enzymes such as cytochrome c oxidase, Cu/Zn
superoxide dismutase, and others (Gupta and
Lutsenko 2009). Apart from this essential role, ionic
copper in excess becomes toxic and mediates the
generation of the highly reactive hydroxyl radical,
able to damage different kinds of biomolecules
(Valko et al. 2005).
This dual role implies that copper uptake and
utilization is under narrow regulation in order to allow
for cell needs and prevent harmful effects. In many
cells, most of the copper is taken up through
evolutionary conserved copper transporters (CTRs)
which include efficient orthologs in humans, hCTR
(Zhou and Gitschier 1997), yeasts, yCtr1, and the
filamentous fungi Podospora anserina, PaCtr3
(Borghouts et al. 2002). After copper is taken inside
liver cells, a Cu-ATPase (ATP7B) transports it across
intracellular membranes. These may be vesicles to
fuse with the cell membrane and excrete the copper
into the bile, or vesicles that may enter the secretory
compartment and supply copper as co-factor to the
synthesis of the cuproenzymes (Gupta and Lutsenko
2009). Additional copper ions bind metallothionein,
but, when in excess, they accumulate in the cytoplasm
and cause oxidative damage (Gaetke and Chow
2003). These deleterious effects of copper are not
evident early in life but may accumulate as we age.
Actually, it is clear that copper is involved in the
pathogenesis of age-associated disorders as Alz-
heimer’s and Parkinson’s disease (Barnham and Bush
2008; Brewer 2010).
The P. anserina ageing model provides interesting
information into putative mechanisms on cellular
ageing. In contrast to most filamentous fungi, the
mycelia of P. anserina wild-type strains attain senes-
cence and may die, after some time of active growth.
However, a mutation in the grisea gene results in
strains with life extension and delay in senescence.
This gene induces the expression of the PaCTR3
permease but, when mutated, leads to its loss of
function and decrease in the uptake of copper into the
cell (Borghouts et al. 2002). Interestingly, senescence
delay observed in the mutant strains may be lost when
they are transformed with a constitutively active
construct containing PaCtr3-cDNA, and senescence
may be postponed when wild-type strains are grown
in media added with a copper chelator (Borghouts et
al. 2001, 2002). Senescent P. anserina wild-type
strains exhibit a PaCTR3 downregulation. However,
they evidence an enhanced metallothionein 1 expres-
sion, confirming an increase in cytosolic copper,
thought to derive from mitochondria (Borghouts et
al. 2002), and further adding to copper intervention in
senescence.
In senescent HDFs, copper-regulated genes such as
heat-shock protein-70 (hspa1a) and metallothionein 2A
(mt2a) were found upregulated, indicating that cyto-
solic copper levels also increase during senescence of
784 AGE (2012) 34:783–794
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HDFs. Thus, the evidence favoring enhanced intracel-
lular copper as longevity modulator, possibly through
the generation of ROS, is strong but is much limited
regarding cellular senescence (Scheckhuber et al.
2009).
Departing from the hypothesis that the oxidative
effect of copper is able to cause cellular senescence,
we aimed to verify whether copper exposure of HDFs
was able to cause the morphological and molecular
alterations typically associated with it. Here, we
provide data showing that copper induces biomarkers
of senescence similarly to other SIPS agents.
Methods
Cell culture procedures
WI-38 HDFs were purchased from The European
Collection of Cell Cultures and were routinely
cultivated in 75 cm2 culture flasks containing 15 mL
of basal medium Eagle (BME) supplemented with
10% fetal bovine serum (FBS) at 37°C in an
atmosphere containing 5% CO2. When confluent,
cells were subcultivated as previously described
(Hayflick and Moorhead 1961). In slowly growing
cultures, the medium was changed every 4 days. To
analyze the effect of copper, subconfluent WI-38
cultures at early cumulative population doublings
(CPDs≤30) were submitted to 250, 500, 750, or
1,000 μM copper sulfate (CuSO4) in BME containing
10% FBS for 24 h. At the end of the exposure, cells
were washed twice with pre-warmed phosphate buffer
saline (PBS) and complete medium (BME with 10%
FBS) was added. Control cultures at the same early
CPDs were incubated with equivalent doses of
sodium sulfate (Na2SO4). BME condition represents
cells treated with complete medium without sodium
or copper sulfate.
Copper cytotoxicity
To assess copper cytotoxicity, cell survival was
measured by neutral red assay immediately after cell
exposure to several concentrations of copper sulfate
(250, 500, 750, and 1,000 μM), as described by
Repetto et al. (2008), and compared with controls.
Briefly, after copper treatment, the medium was
removed, and the cells were incubated with neutral
red solution (40 μg/mL) in BME for 3 h at 37°C. The
cells were subsequently washed with PBS, and the
dye was extracted from the viable cells by their lysis
with acetic acid (1% v/v) in 50% (v/v) ethanol. Optical
density was then measured at 540 nm (Abs540nm)
using a microplate reader (Infinite®200-TECAN).
Control cells, treated with sodium sulfate, represented
100% viability.
Cell proliferation assay
To assess the effect of copper treatment on cell
proliferation, the sulforhodamine B (SRB) assay was
employed (Vichai and Kirtikara 2006). SRB assay
was used for cell density determination, based on the
measurement of cellular protein content (arbitrary
units). For the assay, 10,000 cells per well were plated
onto 96-well plates, submitted to the different treat-
ments, and then fixed at different time-points after
stress (1, 2, 3, and 4 days after exposure) with 10%
trichloroacetic acid (TCA) during 1 h at 4°C. The
TCA-fixed cells were stained for 30 min with 0.057%
(w/v) SRB in 1% acetic acid solution and then were
washed four times with 1% acetic acid. Bound dye
was solubilized with 10 mM Tris base solution
(pH 10), and the absorbance at 510 nm of each well
was recorded using a microplate reader (Infinite®200-
TECAN). Cell growth was estimated considering that,
for each condition, the respective Abs510nm (day 1)=1
arbitrary unit of proliferation index.
Senescence-associated β-galactosidase
At 24 h after copper treatment, cells were trypsi-
nized and seeded in six-well culture plates at a
density of 20,000 cells per well. Forty-eight hours
after plating, the activity of senescence-associated
β-galactosidase (SA β-gal) was determined as
described by Dimri et al. (1995). The proportion
of SA β-gal-positive cells was determined by
counting 400 cells per dish under a microscope,
using duplicates. The proportions of cells positive
for SA β-gal activity are given as percentages of the
total number of cells counted.
Real-time PCR analysis
Total RNA was extracted (RNeasy Plus Mini Kit,
Qiagen™) from cells 3 days after treatments, in at
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least three independent cultures. Total RNA (2 μg)
was converted in cDNA by reverse transcription
reaction. Amplification reaction assays contained
1× SYBR Green Mastermix (Bio-Rad™) and
primers (STAB VIDA, Lda.) at optimal concentra-
tion. The sequences of gene-specific primers are
shown in Table 1. A hot start at 94°C for 3 min
was followed by 40 cycles at 94°C for 1 min, 60/
65°C during 1 min, and 72°C for 1 min using the
iCycler iQ5 real-time polymerase chain reaction
(PCR; Bio-Rad™) thermal cycler. The specificity
of amplification was checked by performing
melting curves and electrophoresis of the amplifi-
cation products.
Western blot analysis
After treatments, WI-38 cells were washed once
with ice-cold PBS and scrapped on ice in a lysis
buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM
EDTA, 0.1% Triton X-100). Cells were homoge-
nized and sonicated for 5 min. The protein content
of these cell extracts was quantified using Bradford
assay (Bradford 1976). An equal amount of protein
(20 μg/lane) from each cell extract was resolved on
SDS-PAGE gels with appropriate polyacrylamide
concentrations. Proteins were blotted to a nitrocellu-
lose membrane and, after blocking with 5% non-fat
dry milk diluted in Tris buffer saline 0.1 M/0.1%
Tween 20 (TBST), were subsequently probed with
the specific primary antibodies overnight at 4°C
(mouse monoclonal antibody anti-p21, Cell Signal-
ing Technology; rabbit polyclonal antibody anti-
fibronectin or anti-TGF β1, Santa Cruz Biotechnol-
ogy, Inc.; and mouse monoclonal antibody anti-
apolipoprotein J, Millipore). After extensive washing
with TBST, immunoblots were then incubated with an
appropriate peroxidase-conjugated secondary antibody
for 1 h at room temperature. After three washes in
TBST, immunoblots were detected using the ECL
Western Blotting Substrate (Pierce™-Thermo Sci-
entific) and recorded by exposure to an X-ray film.
Tubulin was also detected and used as control of
protein loading.
Statistical analysis
Student t test was used to compare the means between
two different conditions. A p value lower than 0.05
was considered statistically significant.
Results
Copper sulfate effect on cellular viability
For the determination of the highest dose of copper
that could be used without being toxic to WI-38
fibroblasts, several concentrations of copper sulfate
were tested. Cells were submitted to 250, 500, 750,
Gene Sequences (5′→3′) Amplicon size (bp)
Apolipoprotein J–F GGA TGA AGG ACC AGT GTG ACA AG 114
Apolipoprotein J–R CAG CGA CCT GGA GGG ATT C
TGF-β1–F AGG GCT ACC ATG CCA ACT TCT 102
TGF-β1–R CCG GGT TAT GCT GGT TGT ACA
p21–F CTG GAG ACT CTC AGG GTC GAA 123
p21–R CCA GGA CTG CAG GCT TCC T
IGFBP3–F CAG AGC ACA GAT ACC CAG AAC TTC 111
IGFBP3–R CAC ATT GAG GAA CTT CAG GTG ATT
Fibronectin–F TGT GGT TGC CTT GCA CGA T 109
Fibronectin–R GCT TGT GGG TGT GAC CTG AGT
HO1–F CCA GCA ACA AGG TGC AAG ATT C 148
HO1–R CAC ATG GCA TAA AGC CCT ACA G
TBP–F TCA AAC CCA GAA TTG TTC TCC TTA T 122
TBP–R CCT GAA TCC CTT TAG AAT AGG GTA GA
Table 1 Primers used for
real-time PCR
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and 1,000 μM CuSO4 for 24 h, and the mean
viability from three independent experiments was
determined for each concentration, assuming that
control cells presented 100% viability. Copper
cytotoxicity was determined by neutral red assay
performed immediately after exposure. As can be
seen in Fig. 1, control cells (incubated with the
highest dose of sodium sulfate) did not show
significant differences in cell viability when com-
pared with BME cells (101.3%). However, cell
viability decreased with increasing concentrations
of copper sulfate. Cells exposed to 250 μM copper
sulfate presented 96.4% of cell viability when
compared with controls. This lowest copper sulfate
concentration was considered as a subcytotoxic
dose, on account that cell exposure to 500, 750,
and 1,000 μM resulted in a substantial decrease in
cellular viability to 41.0%, 21.8%, and 17.8%,
respectively, when compared with controls. The
three highest doses of copper sulfate were consid-
ered cytotoxic since they yielded cell viabilities
lower than 50%. Thus, we decided to emphasize on
250 μM CuSO4 for all the experiments throughout
this study. However, in order to evaluate if a higher
copper concentration was able to provoke more
pronounced senescent effects on cells, the concen-
tration of 500 μM CuSO4 was also tested.
Effect of copper on cell morphology and senescence-
associated β-galactosidase activity
The most evident morphological changes occurring in
cellular senescence of fibroblasts are the increase in cell
surface area/volume and the alteration of their morphol-
ogy from small spindle–fusiform to large flat spread
(Greenberg et al. 1977; Bayreuther et al. 1988). On the
present investigation, cells exposed to 250 or 500 μM
copper sulfate presented altered morphological features
(Fig. 2a), such as enlarged cell surface as well as
stellate outline with thin extensions resembling the
typical senescent-like cell morphology. In agreement
with the results obtained for cellular viability, cell
incubation with 500 μM copper sulfate resulted in a
much lower cell density when compared with the other
conditions (BME, control, and 250 μM copper), as can
be seen in Fig. 2a.
The increased activity of SA β-gal was shown to
be a reliable marker of senescence in non-confluent
fibroblasts (Dimri et al. 1995) and is commonly used
to evidence that. To verify the effects of copper sulfate
Fig. 1 Cell viability after exposure to copper sulfate at different
concentrations for 24 h. Cell viability decreases with increasing
doses of copper sulfate. Control cells, submitted to 1,000 μM
sodium sulfate for 24 h, represent 100% viability and did not
present significant alteration in viability when compared with cells
treated with complete medium (BME). Cell viability was copper
sulfate dose-dependent from 250 to 1,000 μM. However, in
contrast to 250 μM, a subcytotoxic dose that led to 94.6% of cell
viability, cell exposure to the higher doses of copper sulfate, 500,
750, and 1,000 μM, resulted in a decrease in cell viability to
41.0%, 21.8%, and 17.8%, respectively. Data are expressed as
mean±SEM from three independent experiments
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on SA β-gal activity, 500 μM sodium sulfate (control)
and BME (complete medium) were compared, but no
significant differences were detected between both
groups (p=0.23). However, as shown in Fig. 2b, the
percentage of cells positive for the SA β-gal increased
significantly to 19% (p<0.05) and 27% (p<0.01) in
cells exposed to 250 and 500 μM copper sulfate,
respectively, when compared with the 6% of the
control. These phenotypic changes are usually taken
as indicating cellular senescence (Hwang et al. 2009).
Effect of copper sulfate on cell proliferation
Either replicatively or stress-induced, senescent cells
cease proliferating and exhibit cell cycle arrest in G1.
To assess the effect of copper in cell proliferation, the
total mass of cell proteins was determined in arbitrary
units, at different time-points (1, 2, 3, and 4 days)
after stress. For each condition, it was assumed that,
at day 1, the proliferation index was 1. Fig. 3 shows
cell proliferation curves for the different conditions
during 4 days. Both BME and control cells prolifer-
ated approximately at the same rate, showing an
increase in protein content from 1-(day 1) to 3.16-
and 2.91-fold (day 4), respectively. Cells treated
with 250 or 500 μM copper sulfate presented
smaller increases in protein content from 1 (day
1) to 1.81 and 1.40 on day 4, respectively. This
lesser increase in protein content observed for cells
treated with 250 μM represent a decrease in cell
proliferation of about 58% while, for cells exposed
to 500 μM, the proliferation was reduced by 79%,
when compared with the proliferation rate of
control cells.
Fig. 2 Cell morphology
and senescence-associated
β-galactosidase activity
detection on fibroblasts
exposed to 250 or 500 μM
of copper sulfate. a Wi-38
HDFs exposed to 250 or
500 μM CuSO4 presented
enlarged cellular volume
and altered shape, resem-
bling the typical senescent
phenotype that normally
appears on replicatively
senescent fibroblasts. b SA
β-gal-positive cells in-
creased to 19% and 27% in
cells exposed to 250 and
500 μM copper sulfate,
respectively, when com-
pared with control cells
(6%). Data are expressed as
mean±SEM from three
independent experiments.
*p<0.05; **p<0.01 and ns
non-significant, when com-
pared with control
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Gene expression in fibroblasts exposed to copper sulfate
Senescent cells display several typical features which
include an alteration in the expression level of several
senescence-associated genes (Dumont et al. 2000;
Debacq-Chainiaux et al. 2008). The genes encoding
cyclin-dependent kinase inhibitor 1A (p21), apolipopro-
tein J (ApoJ), transforming growth factor beta 1 (TGF
β1), fibronectin, insulin growth factor binding protein 3
(IGFBP3), and heme oxygenase-1 (HO-1) are known to
be overexpressed both in replicatively, and in prema-
turely stress-induced, senescent cells. Transcript levels of
these genes were quantified by real-time PCR in human
fibroblasts 72 h after exposure to copper sulfate, in at
least three independent experiments. Results obtained
from real-time PCR are depicted in Fig. 4. Cells
submitted to 250 μM CuSO4 presented statistically
significant increase in mRNA levels of p21, ApoJ, TGF
β1, fibronectin, IGFBP3, and HO-1 (respectively 2.3-,
2.5-, 2.3-, 3.1-, 3.0-, and 3.4-fold) when compared with
control cells. Cells exposed to 500 μM copper sulfate
did not present consistent variations regarding mRNA
expression of the selected genes (online resource 1).
Such results were interpreted as a consequence of the
toxic effects obtained for this concentration.
Western blot analysis in fibroblasts exposed to copper
sulfate
The protein levels of some of the senescence-
associated genes (fibronectin, p21, TGF β1, and
ApoJ) were assessed by Western blotting. Fig. 5a
shows representative blots of the variations obtained
in the content of each protein, and, in Fig. 5b, the
relative densitometric means from three independent
experiments are plotted. Intracellular levels of fibro-
nectin did not change in WI-38 fibroblasts exposed to
250 μM CuSO4 when compared with control cells.
However, the same copper-treated cells presented
increased protein levels of p21, TGF β1, and ApoJ
(3.7-, 2.0-, and 1.4-fold, respectively) when compared
with controls. There were several attempts in order to
evaluate the protein levels of IGFBP3. However, the
antibody utilized with that purpose was not specific,
and, for that reason, we could not conclude about the
effect of copper on IGFBP3 protein levels. Once
again, incubation of fibroblasts with 500 μM copper
sulfate resulted in inconsistent protein variations
(online resource 2), most probably due to the
cytotoxic effects of such copper concentration.
Discussion and conclusions
Some agents causing oxidation may be toxic to cells
and impose a dramatic limit to their viability.
However, their use in subcytotoxic amount induces a
change in cell structure and gene expression pattern
that directs cells to the condition of senescence. The
present study provides evidence that copper has those
properties and acts in a way similar to other oxidative
agents such as hydrogen peroxide and t-BHP that
Fig. 3 Cell proliferation
curves of human diploid
fibroblasts exposed to 250 or
500 μM of copper sulfate.
Both BME and control cells
presented approximately the
same proliferation rate during
the 4 days after stress. At the
fourth day after treatment,
cells exposed to 250 or
500 μM CuSO4 showed a
decrease in cell proliferation
of about 58% and 79%,
respectively, when compared
with control cells. Data are
expressed as mean±SEM
from three independent
experiments. *p<0.05 when
compared with the same
time-point of the control
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Fig. 4 Evaluation of mRNA
relative levels of several
senescence-associated genes
by real-time PCR. Cells ex-
posed to 250 μM CuSO4
presented a statistically sig-
nificant overexpression of
p21, ApoJ, TGF β1,
IGFBP3, and HO-1 (respec-
tively 2.3-, 2.5-, 2.3-, 3.0-,
and 3.4-fold increase com-
pared with control cells).
mRNA levels of fibronectin
were also increased in cells
treated with copper, although
this variation was not statis-
tically significant when
compared with control cells.
Data are presented as mean±
SEM from at least three
independent experiments.
*p<0.05; **p<0.01 when
compared with control
Fig. 5 Western blot analysis of fibronectin, p21, ApoJ, and
TGF β1 protein levels. a Representative blots for the detection
of the different proteins. Tubulin was used as loading control. b
The resulting bands were quantified using densitometric
analysis of the different signals. Fibronectin intracellular
content remained unaltered after exposure to 250 μM CuSO4,
comparing with controls. Protein levels of p21, TGF β1, and
Apo J were 3.9-, 2-, and 1.4-fold increased, after exposure to
250 μM CuSO4, respectively, when compared with control
levels. Data are expressed as mean±SEM from at least three
independent experiments. *p<0.05; **p<0.01 when compared
with control
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cause SIPS. In fact, when WI-38 fibroblasts were
submitted to copper sulfate for a limited time, they
evidenced elevated viability at 250 μM that was
strongly reduced at 500 μM and more. The cytotoxic
effects of 500 μM copper sulfate were further
evidenced in the study of mRNA and protein
expression. For this reason, 250 μM was considered
subcytotoxic and employed thereafter to verify copper
ability to cause SIPS.
Sound data obtained along decades led to the concept
that the progressive decline in the proliferative potential
followed by growth arrest is the defining feature of the
in vitro replicative senescence of fibroblasts (Goldstein
1990; Smith and Pereira Smith 1996) and SIPS
(Toussaint et al. 2000). In the present investigation,
cell proliferation was found substantially reduced
during the 4 days after treatment with 250 μM of
CuSO4, when compared with the control cells. These
findings are in agreement with previous SIPS studies.
In fact, F65 fibroblasts exposed for 2 h to 200 μM
H2O2 exhibited a sluggish or absent mitogenic
response to several growth stimuli (Chen and Ames
1994). In addition, WI-38 fibroblasts cultivated under
mild hyperoxia (von Zglinicki et al. 1995) or submitted
to successive stresses under t-BHP treatment (Dumont
et al. 2000) showed a drastic decrease in their
proliferative capacity, too.
Cell morphology is an important criterion to
evaluate the senescence of human fibroblasts in vitro,
which usually enlarge, flatten, and loosen spindle
morphology and exhibit reduced density. These
features were observed in WI-38 fibroblasts 3 days
after treatment with copper sulfate, similar to what is
seen in other SIPS cellular models (Chen and Ames
1994; Wang et al. 2004). The same stands for SA β-
gal activity which was shown to be a reliable marker
of senescence in non-confluent cultures of fibroblasts
(Dimri et al. 1995) and is used regularly with that
purpose. In the present study, WI-38 fibroblast
cultures submitted to 250 μM copper sulfate for
24 h showed a higher proportion of cells positive for
SA β-gal. This finding parallels other SIPS-inducing
conditions such as exposure of cells to successive
stresses with t-BHP or ethanol (Debacq-Chainiaux et
al. 2008), subcytotoxic levels of hydrogen peroxide
(Zdanov et al. 2006), or UVB radiation (Debacq-
Chainiaux et al. 2005).
There are several genes whose mRNA levels
increase both in replicative and premature senescent
HDFs indicating a change in gene expression.
Debacq-Chainiaux and colleagues evaluated three
different HDF models of senescence and showed that
the mRNA levels of senescence-associated genes such
as fibronectin, p21, ApoJ, IGFBP3, and TGF β1 were
similarly increased in the three cellular models
(Debacq-Chainiaux et al. 2008). Those findings
prompted us to study their relative transcript levels
by real-time PCR, in WI-38 HDFs, 72 h after
exposure to copper sulfate.
As already mentioned, the hallmark of cellular
senescence is the irreversible arrest of cell division.
Senescent cells have been shown to arrest in the G1
phase of cell cycle (Chen et al. 1998) and do not
resume proliferation when challenged by physiologi-
cal mitogens. In mammals, the main regulators of cell
cycle progression through G1 phase are heterodimers
composed of a cyclin-dependent kinase (CDK4 or
CDK6 in this phase) and one member of the D class
of cyclins. However, the progression is stalled when
the CDK inhibitor p21 exhibits sustained overexpres-
sion as occurs in replicative senescence (Stein et al.
1990) and in premature senescence induced by H2O2
(Chen et al. 1998), t-BHP (Dumont et al. 2000), or
UVB (Debacq-Chainiaux et al. 2005). The present
study, in accordance with the reduced proliferation,
provides evidence that p21 transcript levels and
protein content are also increased in CuSO4-exposed
WI-38 cells.
Fibronectin is an essential extracellular matrix
component involved in cell adhesion, cytoskeletal
organization, mediation of external mitogenic signals,
andwound repair. Fibronectin gene has been found to be
overexpressed in senescent pig skin fibroblasts (Martin
et al. 1990), in fibroblasts derived from patients with
Werner ageing syndrome (LeckaCzernik et al. 1996),
and also in several ageing models of human fibro-
blasts, such as replicative senescence, premature
senescence induced by t-BHP or ethanol (Debacq-
Chainiaux et al. 2008), and premature senescence
induced by UVB radiation (Debacq-Chainiaux et al.
2005). Increased expression of fibronectin was found
to positively correlate with cell surface increase
observed during senescence of HDFs, suggesting that
it may underlie or contribute to replicative senescence
morphological changes (Kumazaki et al. 1993). Here,
copper-treated WI-38 human fibroblasts presented
about threefold increased fibronectin mRNA expres-
sion when compared with control cells, although its
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intracellular protein content, assessed by Western
blotting, did not increase after exposure to 250 μM
copper sulfate. One possible explanation to this
discrepancy is that fibronectin secretion rate might
increase with increasing concentrations of copper
sulfate, resulting in a faster secretion of fibronectin to
the extracellular space, where it usually localizes. This
specific point could be elucidated by the quantification
of secreted fibronectin in the culture media where cells
were grown, but regrettably, it was not evaluated.
Apolipoprotein J, also known as clusterin, is an 80-
kDa glycoprotein consisting of two disulfide-linked
subunits, alpha and beta, and is constitutively synthe-
sized and secreted by many cell types. ApoJ is mostly
recognized as an extracellular chaperone which
interacts with many different proteins and inhibits
their stress-induced precipitation (Poon et al. 2002)
and is involved in numerous physiological processes
(Trougakos and Gonos 2006). ApoJ gene is also very
sensitive to cellular stressful conditions, especially
oxidative stress. ApoJ overexpression was observed
in replicatively senescent human fibroblasts and
also in prematurely senescent fibroblasts induced by
t-BHP, ethanol (Debacq-Chainiaux et al. 2008), or
UVB (Debacq-Chainiaux et al. 2005) and is thus
considered a faithful biomarker of cellular senescence
(Trougakos and Gonos 2006). Its expression was
enhanced in the current study too. Due to the varied
functional involvement of ApoJ, there is uncertainty
regarding its specific intracellular effects. As a wide-
range chaperone, a likely explanation is to endow
cells with protective survival tools when protein
structure may become deranged due to stresses. Yet,
another role is to direct damaged proteins for
destruction, employing a different mechanism for the
same survival purpose. In fact, it was recently
reported that ApoJ expression was enhanced in cells
grown in excess of copper. Under such conditions,
there was evidence for the enhancement of interaction
ApoJ/ATP7B copper transporter and its degradation,
particularly when mutated (Materia et al. 2011).
TGF β1 is a pleiotropic cytokine involved in many
cell functions like cell growth, differentiation, and
biosynthesis of extracellular connective tissue. TGF
β1 was shown to be overexpressed in replicative,
t-BHP-, and ethanol-induced senescence of WI-38
HDFs (Pascal et al. 2005). More specifically, it has
already been demonstrated that TGF β1 overexpres-
sion is required for the appearance of several
biomarkers of cellular senescence, such as the
induction of senescent morphogenesis, increased
mRNA level of senescence-associated genes, such as
ApoJ and fibronectin, and increased senescence-
associated β-galactosidase activity, after exposure of
HDFs to subcytotoxic stress with H2O2 (Frippiat et al.
2001; Frippiat et al. 2002) or UVB (Debacq-Chai-
niaux et al. 2005). Similar to other stress-induced
premature senescence cellular models, WI-38 HDFs
exposed to 250 μM copper sulfate was followed by
increased mRNA and protein levels of TGF β1.
TGF β1 is known to induce HO-1 expression in
pulmonary epithelial cells (Ning et al. 2002), human
renal proximal tubule cells (Hill-Kapturczak et al.
2000), and also in WI-38 HDFs (Pascal et al. 2007).
HO-1 expression is transcriptionally activated by
agents that generate reactive oxygen species (Soares
and Bach 2009), and it has been already shown to be
overexpressed in prematurely senescent WI-38 HDFs
after exposure to t-BHP and ethanol (Pascal et al.
2007). The present study reports a similar effect in
WI-38 fibroblasts with 250 μM copper sulfate.
In addition, TGF β1 is also known to control
synthesis and secretion of IGFBP3 by HDFs (Martin
and Baxter 1991). IGFBP3 expression is associated
with inhibition of cell proliferation and cellular
senescence, and, again, its overexpression in RS and
SIPS fibroblasts induced by t-BHP, ethanol (Debacq-
Chainiaux et al. 2008), or UVB (Debacq-Chainiaux et
al. 2005) was described. It has been suggested that
growth arrest in premature senescence partly depends
on TGF β1 via the overexpression of IGFBP3
(Debacq-Chainiaux et al. 2008). In accordance,
fibroblasts exposed to copper sulfate presented in-
creased transcript levels of IGFBP3 in a fashion
similar to TGF β1.
The results presented herein show that subcyto-
toxic concentration of copper sulfate is able to induce
senescence features on WI-38 human fibroblasts.
Similar to the effects of other well-known SIPS
agents, they are observed past adaptative conditions
related to immediate gene response and are varied:
they include changes in proliferation, in SA β-gal
activity, and in gene expression. The coherent pattern
of their change gives credit to the inclusion of copper
as a SIPS-inducing agent.
It is hoped that further studies addressing the
mechanism and biological meaning of copper-
associated cell senescence will improve the under-
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standing of the establishment and progression of brain
and liver disorders as Alzheimer’s and Wilson’s
diseases. In the first, copper not only interacts with
amyloid precursor protein through a binding domain
but also promotes amyloid β peptide crosslinks and
aggregation through metal-mediated oxidative stress
(Barnham and Bush 2008). In Wilson’s disease, a
deficient intracellular transport of copper results from
a structural abnormality of the ATP7B translocator,
whose level is regulated by the senescence biomarker
ApoJ/clusterin (Materia et al. 2011).
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Electronic supplementary material 
Online resource 1: 
Effect of 500 μM copper sulfate on mRNA transcript levels of several senescence-associated genes. The 
incubation of WI-38 fibroblasts with the lower cytotoxic copper concentration (500 μM) resulted in non-
significant variations on p21, ApoJ, TGF β1, fibronectin, and HO-1 gene expression, when compared with 
controls. In addition, IGFBP3 mRNA levels were 1.7-fold increased in 500 μM CuSO4-treated cells, comparing 
with control cells. When compared with the consistent upregulation of the several senescence-associated genes 
observed for cells exposed to 250 μM copper, gene expression variations obtained with 500 μM copper sulfate 
were senseless, suggesting that the transcriptional machinery of these cells were seriously compromised due to 
the toxic effects of the dose. Data are presented as mean ± SEM from at least three independent experiments. 
*p < 0.05 when compared with control.
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Online resource 2: 
Western blot analysis of fibronectin, p21, ApoJ, and TGF β1 protein levels in cells submitted to 500 μM copper 
sulfate. (a) Representative blots for the detection of the different proteins. Tubulin was used as loading 
control. (b) The resulting bands were quantified using densitometric analysis of the different signals. Protein 
levels of p21 were found significantly increased (3.7-fold) in WI-38 fibroblasts treated with 500 μM copper 
sulfate for 24h, when compared with controls. Both fibronectin and TGF β1 intracellular protein levels were 
decreased, and ApoJ protein content did not alter after exposure to the cytotoxic dose of copper, when compared 
with control cells. These inconsistent protein variations may originate from cellular metabolic alterations 
reflecting the cytotoxic effects of copper concentration used. Data are expressed as mean ± SEM from at least 
three independent experiments. *p < 0.05; **p < 0.01 when compared with control  
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Abstract
The aging process is characterized by progressive accumulation of damaged biomolecules in the 
endoplasmic reticulum, as result of increased oxidative stress accompanying cellular senescence. 
In agreement, we hypothesized that WI-38 human cellular models of replicative senescence and 
stress-induced premature senescence (SIPS) induced by hydrogen peroxide (H
2
O
2
-SIPS) or copper
sulfate (CuSO
4
-SIPS) would present endoplasmic reticulum chaperoning mechanisms impairment
and unfolded protein response  activation. Results show that in replicative senescence and CuSO
4
-
SIPS, immunoglobulin binding protein, calnexin, protein disulfide isomerase, and ER oxireductin-1 
levels adjust to restore proteostasis and inositol-requiring enzyme-1 (IRE1)-, activating transcription 
factor 6 (ATF6)-, and pancreatic ER kinase (PERK)-mediated unfolded protein response are 
activated. However, H
2
O
2
-SIPS does not exhibit IRE1 and ATF6 pathways activation but a PERK-
mediated upregulation of CCAAT/enhancer-binding protein homologous protein, showing that 
CuSO
4
-SIPS mimics better the endoplasmic reticulum molecular events of replicative senescence
than H
2
O
2
-SIPS. Moreover, unfolded protein response activation is required for both SIPS models
induction, because PERK and IRE1 inhibitors decreased senescence-associated beta-galactosidase 
appearance. In CuSO
4
-SIPS, the decrease in senescence levels is associated with PERK-driven,
but IRE1 independent, cell cycle arrest while in H
2
O
2
-SIPS cell proliferation is PERK independent.
These results add a step further on the molecular mechanisms that regulate senescence induction; 
moreover, they validate CuSO
4
-SIPS model as a useful tool to study cellular stress responses
during aging, hoping to postpone age-related health decline.
Key Words: ER stress—Replicative senescence—Copper—Human fibroblasts—SIPS  
The increase of elderly population raised interest in the mecha-
nisms underlying the progressive functional decline and homeostasis 
imbalance that associate with aging. At the molecular level, it is char-
acterized by the continued accumulation of damaged biomolecules, 
as proteins, which impinge on cell and tissue function. Actually, a 
role was ascribed to unfolded/misfolded proteins in the normal aging 
process and the establishment of age-related entities as Alzheimer 
and Parkinson diseases (1,2). Oxidative stress seems to be a major 
contributor to such age-related accumulation of abnormal proteins 
(3,4).
The endoplasmic reticulum (ER) is a target for endogenously gen-
erated reactive oxygen species along aging, as evidenced by increased 
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speci"c ER resident proteins oxidation (5) and consequent organelle 
activity impairment (6). Nevertheless, to prevent protein misfolding, 
accumulation and aggregation, ER possesses a protein quality control 
chaperoning system that includes key chaperones and enzymes, such 
as immunoglobulin binding protein (BiP), calnexin, protein disul"de 
isomerase (PDI), and ER oxireductin-1 (Ero1). A "ne regulation of 
their expression must exist to avoid protein aggregation and cellu-
lar damage, but when proteostasis disruption appears, an adaptive, 
coordinated ER stress response or unfolded protein response (UPR) 
is activated (7). At the cellular level, this complex response is medi-
ated by three ER transmembrane sensors: pancreatic ER kinase -
like ER kinase (PERK), activating transcription factor-6 (ATF6), and 
inositol-requiring enzyme-1 (IRE1). These UPR pathways limit ER 
abnormal protein load and alleviate ER stress by attenuating pro-
tein translation (8), upregulating ER chaperones (9), and degrading 
misfolded proteins in the proteasome by an ER-associated degrada-
tion process (10). If these protective cellular responses do not restore 
normal ER functioning, apoptosis is activated (7,11).
The ef"ciency of this protein quality control system seems to 
be compromised during aging, as several studies demonstrated an 
age-related decrease on the expression levels of some ER molecular 
chaperones and folding enzymes (12,13). However, most of them 
used different tissues from aged rodents (14–16), whereas ER stress 
response in in vitro nonmodi"ed human cellular models of senes-
cence was never addressed.
Cellular senescence was "rstly described by Hay$ick and 
Moorhead, who demonstrated that serially cultivated human dip-
loid "broblasts (HDFs) ceased dividing after a number of population 
doublings (PDs) and became unresponsive to mitogenic stimuli, thus 
entering in a condition termed replicative senescence (RS) (17). In 
addition, cells in RS exhibit dramatic changes in morphology, gene 
expression and organelle structure, mass, and function when com-
pared with proliferating cells (for a review see Ref. (18)).
Besides RS, a senescent phenotype may be prematurely achieved 
when HDFs are submitted to subcytotoxic doses of oxidative stress 
inducers such as hydrogen peroxide (19), ultraviolet-B radiation 
(20), or copper sulfate (21). Cells in this stress-induced premature 
senescence (SIPS) condition display features of RS, including the 
typical senescent morphology and gene expression pro"le (22). Such 
induced models are frequently used to study molecular mechanisms 
of cellular senescence.
Taking into account the increased oxidative stress accompanying 
RS and SIPS human cellular models of aging, it was hypothesized 
that such conditions would favor ER stress establishment, distur-
bance of ER chaperoning mechanisms, and UPR pathways activa-
tion. In fact, in this study, the activation of protective IRE1-, ATF6-, 
and PERK-mediated ER stress responses is shown in RS and SIPS 
human cellular models. Moreover, our data show that PERK and 
IRE1 activation are necessary for the induction of senescence in 
CuSO
4
- and H
2
O
2
-SIPS models.
Methods
Cell Culture
WI-38 HDFs, purchased from the European Collection of Cell 
Cultures, were cultivated in complete medium composed of basal 
medium Eagle (BME) supplemented with 10% fetal bovine serum, 
at 37°C in a 5% CO
2
 atmosphere. The WI-38 HDFs are consid-
ered to be young below 30 PDs and enter senescence at 45 PDs 
or above. Cells unable to make a PD within 3 weeks were in RS. 
For the induction of SIPS with hydrogen peroxide (H
2
O
2
-SIPS) or 
copper sulfate (CuSO
4
-SIPS), young WI-38 HDFs were exposed to 
subcytotoxic concentrations of H
2
O
2
 (50, 75, or 100 µM) or CuSO
4
 
(250 or 350 µM) for 2 or 24 hours, respectively. Then, cells were 
washed with phosphate buffered saline (PBS) and replaced with 
fresh complete medium. After a 72-hour resting period, cells were 
processed for protein or gene expression assessment techniques. 
Control conditions for each cellular model were: young HDFs for 
RS, BME for H
2
O
2
-SIPS, and sodium sulfate for CuSO
4
-SIPS. For the 
inhibition of PERK- or IRE1-mediated ER stress response, 120 nM 
of PERK-inhibitor GSK2606414 or 10 µM of IRE1-inhibitor 4µ8c 
(Cat No. 516535 and 412512, respectively, Calbiochem) were added 
to the medium 1 hour prior to SIPS induction and were maintained 
throughout the experiments. Control cells were incubated with the 
inhibitors respective vehicle.
Cell Viability Assay
Cell survival was evaluated using neutral red assay immediately after 
exposure to CuSO
4
 or H
2
O
2
, either in the presence or absence of 4µ8c 
or GSK2606414 inhibitors, and compared to controls. In brief, after 
treatments, the medium was removed and cells were incubated with 
neutral red in BME (40 µg/mL) for 3 hours at 37°C. They were sub-
sequently washed with PBS, and the dye was extracted from viable 
cells with 1% acetic acid in 50% ethanol. Optical density was meas-
ured at 540 nm using a microplate reader (In"nite 200––TECAN). 
Control cells represented 100% viability.
Senescence-Associated β-Galactosidase Detection
Cells were seeded in six-well culture plates, 20,000 cells/well; 
after 48 hours, the senescence biomarker senescence-associated 
β-galactosidase (SA beta-gal) was detected as described (23). The 
proportion, in percentage, of SA beta-gal positive cells in each condi-
tion was determined by microscopically counting 400 total cells/well 
from at least three independent experiments.
Cell Proliferation
To assess the different conditions effect on cell proliferation, sul-
forhodamine B (SRB) assay was used for cell density determination, 
based on cellular protein content (24). Brie$y, 10,000 cells/well were 
plated onto 96-well plates, submitted to the treatments, and "xed at 
different time-points after stress (0, 1, 2, 3, and 4 days) with 10% 
trichloroacetic acid (TCA), 1 hour at 4°C. The TCA-"xed cells were 
stained for 30 minutes with 0.057% (w/v) SRB in 1% acetic acid 
solution and then washed four times with 1% acetic acid. Bound dye 
was solubilized with 10 mM Tris base solution and the absorbance at 
510 nm of each well was recorded using a microplate reader (In"nite 
200––TECAN).
Western Blot
WI-38 cells were washed with PBS and scrapped on ice in a lysis 
buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% 
Triton X-100) supplemented with protease inhibitors cocktail 
(Sigma-Aldrich). Upon Bradford assay, 20 µg of protein from each 
cell extract were resolved by sodium dodecyl sulfate–polyacryla-
mide gel electrophoresis. Proteins were blotted into a nitrocellu-
lose membrane; after blocking with 5% nonfat dry milk diluted 
in Tris-buffered saline supplemented with 0.1% tween 20 (TBST), 
were probed with speci"c primary antibodies (anti-BiP #3177, 
anti-calnexin #2679, anti-Ero1 #3264, anti-PDI #3501, anti-
IRE1 #3294, anti-PERK #5683, anti-phospho-eIF2α #3398—
Cell Signaling Technology; anti-P-JNK sc-6254, anti-ATF6 
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sc-14250—Santa Cruz Biotechnology, Inc.; and anti-tubulin 
T5168—SigmaAldrich) overnight at predetermined optimal dilu-
tions. After washing with TBST, immunoblots were incubated 
with appropriate peroxidase-conjugated secondary antibodies for 
1 hour, detected using ECL western blotting substrate (Pierce—
Thermo Scienti"c), and visualized with ChemiDocTM XRS 
(BioRad Laboratories). Results were quanti"ed by densitometry 
using the Image Lab software.
Real-Time PCR
Total RNA extracted (PureLink RNA Mini Kit, Ambion) from 
cells derived from at least three independent cultures was con-
verted into cDNA by reverse transcription reaction. Ampli"cation 
reaction assays contained SYBR Green Mastermix (Maxima 
SYBR Green/ROX qPCR Master Mix, Thermo Scienti"c) and 
primers (STAB VIDA, Lda.) at optimal concentration. The primer 
sequences were: BiP, 5-GTT CTT GCCGTTCAAGGTGG-3 and 
5-TGGTACAGTAACAACTGCATG-3; CCAAT/enhancer-bind-
ing protein homologous protein (CHOP), 5-CAGAAC CAGCA 
GAGGTCACA-3 and 5-AGCTGTGCCACTTTCCTTTC-3; p21, 
5-CTGGA GACT CTCAGGGTCGAA-3 and 5-CCAGGACTGCA
GGCTTCCT-3; and TATA box binding protein (TBP), 5-TCAAACCC
AGAATTGTTCTCCTTAT-3, and 5-CCT GAATCCCTTTAGAATA
GGGTAGA-3. The protocol used for the quantitative real-time
polymerase chain reaction (qPCR) was: 95°C (10 minutes), 40
cycles of 95°C (15 seconds), and 60°C (1 minute). For the spe-
ci"c ampli"cation of the spliced variant of human X box-binding
protein 1 (XBP1s), the primer sequences used were: 5-GGTCTGC
TGAGTCCGCAGCAGG-3’ and 5-GGGCTTGGTATATATGTGG-3;
and the qPCR protocol was: 95°C (10 minutes), 40 cycles of 95°C
(15 seconds), 55°C (30 seconds), and 72°C (30 seconds). The
qPCR was performed in the StepOnePlus thermal cycler (Applied
Biosystems). The TBP was the selected housekeeping gene when cal-
culating relative transcript levels of the target genes.
Statistical Analysis
Student’s t test was used to compare the means between two differ-
ent conditions. A p value lower than .05 was considered statistically 
signi"cant.
Results
Cell Viability, Proliferation and SA β-Gal Detection in 
CuSO
4
- and H
2
O
2
-SIPS Cells
The CuSO
4
-SIPS cellular model was recently established by exposing 
WI-38 "broblasts to 250 µM CuSO
4
 for 24 hours (21). As 500 µM 
CuSO
4
 was found to greatly affect cell viability, here, we evalu-
ated the cytotoxicity of an intermediate concentration (350  µM) 
to include a higher sublethal dose of copper in all experiments. As 
presented in Figure  1A, "broblasts treated with 250 or 350  µM 
CuSO
4
 exhibited 75% and 61% viability, respectively. Moreover, 
cells treated with 50, 75, or 100  µM H
2
O
2
, the most commonly 
used SIPS inducer, had 97%, 94%, or 87% of cell survival when 
compared with controls.
Both SIPS and RS conditions had a signi"cant increase in the per-
centage of senescent cells as assessed by the positivity for SA beta-gal 
activity (Figure 1B). Control cells presented 4% of SA beta-gal posi-
tive cells, whereas cells submitted to 250 and 350 µM CuSO
4
 pre-
sented 36% and 39%, respectively. In addition, "broblasts treated 
with 50, 75, and 100 µM H
2
O
2
 exhibited 20%, 27%, and 34% of 
stained cells, respectively. Finally, in RS, 80% of the total number of 
cells were positive for SA beta-gal.
Cell proliferation inhibition is another typical and frequently 
evaluated marker of the senescence phenotype. Similarly to previous 
observation (21), 3 days after removing the stressor, cells exposed to 
250 or 350 µM CuSO
4
 presented 49% and 74% of cell proliferation 
inhibition, respectively, when compared with controls (Figure 1C). 
In addition, cell proliferation was 40% and 56% inhibited in "bro-
blasts treated with 75 or 100 µM H
2
O
2
, respectively, whereas 50 µM 
H
2
O
2
 treated cells did not present signi"cant inhibition (3%) com-
pared with controls (Figure 1D). In turn, RS cells inhibition was 90% 
of young actively proliferating cells, as expected (Figure 1C and 1D).
Expression of Key ER Chaperones and Enzymes Is 
Altered in RS and SIPS Fibroblasts
BiP, an hsp70 family member (25), is one of the "rst molecular 
chaperones encountered by newly ER synthesized polypeptides. Its 
expression in all three cellular senescence models was evaluated by 
qPCR (Figure 2A). Fibroblasts exposed to 250 or 350 μM CuSO
4
 
presented a 2.9- and 5.7-fold increase in BiP transcript level, respec-
tively, compared with controls, and RS cells exhibited a 24-fold 
BiP mRNA increase comparatively to young cells. In contrast to 
copper-treated cells, H
2
O
2
-SIPS cells showed BiP mRNA decrease 
after exposure to 50, 75, or 100 μM H
2
O
2
 (0.7-, 0.6- and 0.6-fold 
variations, respectively) when compared with controls. To con"rm 
these gene expression variations, BiP protein levels were assessed by 
western blot in the different senescence models (Figure 2B and 2C). 
Fibroblasts exposed to 250 or 350 µM CuSO
4
 or in RS exhibited 
2.5-, 2.2- and 5.9-fold increase in BiP content; in turn, H
2
O
2
-treated 
cells did not present signi"cant changes in BiP protein levels when 
compared with controls.
Another analyzed chaperone was calnexin, an ER transmem-
brane lectin, responsible for the quality control of newly synthesized 
glycoproteins. Calnexin protein levels decreased in all cellular mod-
els (Figure 2B and 2C). Fibroblast exposure to 250 or 350 µM CuSO
4
 
or to 50, 75, or 100 µM H
2
O
2
 resulted in calnexin level reduction of 
28% or 23% and 38%, 29%, or 32%, respectively, when compared 
with controls. Similarly, for the RS cellular model, calnexin levels 
were also lowered by about 33%.
Disul"de bond formation is an additional critical step in the 
folding of most newly synthesized proteins that translocate through 
ER membrane. PDI, a thioredoxin superfamily of proteins member, 
catalyzes the process through thiol-disul"de oxidation, reduction, 
and isomerization (26). Moreover, it is promoted with the help of 
Ero1 that maintains a suitable oxidizing environment and is thus, 
together with PDI, a major intervener in protein disul"de bond for-
mation. The PDI and Ero1 protein levels were evaluated in the three 
senescence models (Figure 2B and 2C). Fibroblasts exposed to 250 
or 350 µM CuSO
4
 showed PDI levels reduction to 78% or 55% 
of the control cells’ levels, respectively. In addition, cells treated 
with 50, 75 or 100 µM H
2
O
2
 presented a 27%, 34%, and 30% 
PDI levels decrease, respectively, when compared with controls. 
In RS model, PDI protein reduced 55% compared with controls. 
Regarding Ero1 protein, levels were enhanced in all three mod-
els comparatively to controls (Figure 2C). CuSO
4
-SIPS "broblasts 
(both 250 and 350 µM treated) presented about 2-fold increase in 
Ero1 content, whereas in cells treated with 50, 75, or 100 µM H
2
O
2
 
the raise was of 2-, 3.2-, and 3.7-fold, respectively. Furthermore, in 
RS cells, Ero1 protein levels were 5.6-fold enhanced comparatively 
to young cells.
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ER Stress Response Transduction in RS and SIPS 
Human Cellular Models
ER stress is transmitted to the cytoplasm through IRE1, PERK, 
and ATF6 transmembrane ER sensor proteins that remain inac-
tive while bound to BiP through their luminal domain. However, 
when unfolded/misfolded proteins accumulate in ER lumen, BiP 
is recruited to chaperone them, which results in sensors unbind-
ing and consequent activation of their transduction pathways 
(27).
IRE1 Signaling: XBP1 Splicing and Jun N-Terminal 
Kinase Activation
IRE1 has an ER luminal N-terminal domain, a single-pass transmem-
brane segment and a C-terminal cytosolic region containing both 
a Ser/Thr protein kinase and a endoribonuclease (RNase) domain 
(28). In ER stress conditions, BiP is released from IRE1 N-terminal 
domain allowing oligomerization and phosphorylation of its cyto-
solic domain, which activates IRE1 signaling pathway (Figure 3A). 
Once activated, C-terminal cytosolic domain of IRE1 acquires 
RNase activity and cleaves 26 nucleotides from XBP1 mRNA gen-
erating an mRNA spliced variant (XBP1s). In addition, IRE1 also 
plays a role in signaling because its activated kinase domain interacts 
with TNF receptor-associated factor 2 leading to the phosphoryla-
tion/activation of the c-Jun N-terminal kinase (JNK) (29). Activated 
JNK can then determine downstream events that may contribute to 
cell survival or to apoptosis (11,30).
To evaluate whether WI-38 "broblasts senescence activates the 
IRE1 branch of ER stress response, its levels were assessed in the 
three cellular senescence models (Figure 3B and 3C). The IRE1 pro-
tein was increased by 2- and 2.5-fold in cells exposed to 250 and 
350 μM CuSO
4
, respectively, when compared with controls. In addi-
tion, RS cells presented a 6.7-fold augmentation in IRE1 relatively 
to young "broblasts. In addition, both RS and CuSO
4
-SIPS imparted 
IRE1 functional changes that activated its kinase and C-terminal 
RNase domains. Phosphorylation levels of JNK (P-JNK) were raised 
in copper-treated cells (1.5-fold) and in RS model (3-fold) when 
compared with their controls. Furthermore, assessment of XBP1s 
transcript levels by qPCR revealed that both models presented a near 
2.5-fold increase in XBP1s mRNA content (Figure 3D). In contrast, 
H
2
O
2
-treated cells did not evidence signi"cant variations in IRE1 
and P-JNK levels (Figure 3B and 3C), but showed a dose-dependent 
decrease on XBP1s transcripts (Figure  3D), when compared with 
controls.
Figure 1. Subcytotoxic concentrations of CuSO
4
 and H
2
O
2
 induce senescence in WI-38 human diploid fibroblasts. (A) Cell viability was measured using neutral 
red assay immediately after exposure to the different concentrations of CuSO
4
 or H
2
O
2
, assuming that the control condition exhibited 100% of viable cells. (B) The 
percentage of cells positive for senescence associated beta-galactosidase activity (SA beta-gal) is plotted for cells in H
2
O
2
-stress-induced premature senescence 
(SIPS), CuSO
4
-SIPS, or replicative senescence (RS). (C and D) Cell proliferation in CuSO
4
-SIPS, H
2
O
2
-SIPS, and RS fibroblasts was assessed using sulforhodamine 
B assay. Data are expressed as mean ± SEM from at least three independent experiments.
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Figure  2. Expression of key endoplasmic reticulum chaperones and enzymes is altered in both replicative senescence (RS) and stress-induced premature 
senescence (SIPS) fibroblasts. (A) Relative transcript levels of immunoglobulin binding protein (BiP) were quantified by qPCR after normalization to TATA 
box binding protein expression for the three cellular models of senescence. (B) BiP, calnexin, ER oxireductin-1, and protein disulfide isomerase proteins were 
detected by Western blot and (C) their relative protein levels were quantified based on densitometry relative to tubulin in the cellular extracts from RS, CuSO
4
-, 
and H
2
O
2
-SIPS cellular models. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; **p < .01; ***p < .001; and n.s.=
nonsignificant when compared with control.
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PERK Pathway: Phosphorylation of Eukaryotic 
Translation Initiation Factor 2α and CHOP Induction
PERK is an ER transmembrane protein with a cytoplasmic C-terminal 
domain with Ser/Thr kinase activity and a luminal N-terminal BiP 
binding domain, similar to that of IRE1 (31). As misfolded/unfolded 
proteins increase in ER lumen, BiP dissociates from PERK result-
ing in its oligomerization, autophosphorylation, and kinase domain 
activation (Figure 4A). Activated PERK phosphorylates eukaryotic 
translation initiation factor 2α (eIF2α), which leads to inhibition 
of protein translation and ER protein-folding load reduction (9). In 
addition, eIF2α phosphorylation results in the selective translation 
of activating transcription factor-4 (ATF4) (32), which promotes the 
expression of CHOP, a transcription factor that can either mediate 
ER stress-induced apoptosis (33) or an autophagy mediated cytopro-
tective response (34).
In this study, PERK and phopshorylated-eIF2α (p-eIF2α) pro-
tein levels were assessed by western blot (Figure 4B and 4C), and 
CHOP transcription levels were evaluated by qPCR (Figure 4D) in 
H
2
O
2
-SIPS, CuSO
4
-SIPS, and RS WI-38 human "broblasts. When 
compared with controls, PERK protein consistently increased in 
all three models. Cells exposed to 250 or 350 µM CuSO
4
 exhibited 
2.1- or 2.5-fold increase, respectively; similarly, cells treated with 
50, 75, or 100 µM H
2
O
2
 presented 1.8-, 2.8-, or 2.7-fold augmenta-
tion, respectively; and RS cells showed 4.9-fold rise in PERK abun-
dance when comparing with controls. Accordingly, p-eIF2α levels 
were also increased in the three cellular models studied herein, 
corroborating PERK activation during cellular senescence: CuSO
4
-
SIPS cells showed a 3.9- or 5.2-fold increase when exposed to 250 or 
350 µM CuSO
4
, respectively; 75 and 100 µM H
2
O
2
-treated cells pre-
sented 2.3- and 3.0-fold higher levels of p-eIF2α, respectively; and 
RS "broblasts exhibited a 3.5-fold activation of p-eIF2α when com-
pared with controls. In contrast, CHOP mRNA levels were slightly 
diminished in CuSO
4
-SIPS, RS, and 50 μM H
2
O
2
-treated "broblasts, 
corresponding to a decrease of about 25%, whereas cells exposed 
to 75 or 100 μM H
2
O
2
 exhibited a statistically signi"cant 1.3-fold 
increased CHOP expression when compared with controls.
ATF6 Activation by Proteolytic Cleavage
ATF6 is a 90 kDa ER transmembrane protein with a DNA binding 
motif in its cytosolic portion. In ER stress conditions, BiP dissoci-
ates from ATF6 and allows its transport to the Golgi compartment, 
where it is activated by proteolytic cleavage (Figure 5A). The 50 kDa 
cleaved form – ATF6(p50), now a transcription factor, binds to a 
ER stress response element and regulates the expression of genes 
encoding ER chaperones and folding enzymes (3) and also XBP1 
and CHOP (9).
To evaluate ATF6 activation, ATF6(p50) was semi-quanti"ed in 
extracts from the three cellular models (Figure 5B). Cells exposed 
to 250 or 350 µM CuSO
4
 presented a signi"cant 1.7- or 2.2- fold 
increase in ATF6(p50) levels; RS cells, although in a statistically 
nonsigni"cant fashion (p = .09), exhibited higher levels (4.5-fold) 
of activated ATF6 when compared with controls. Cells treated with 
Figure  3. Inositol-requiring enzyme-1 (IRE1)–X box-binding protein 1 (XBP1s) axis of endoplasmic reticulum (ER) stress response is activated in RS and 
copper-induced senescence. (A) Schematic representation of IRE1 pathway activation: the accumulation of misfolded proteins in the ER leads to the release of 
immunoglobulin binding protein from IRE1 luminal domain resulting in IRE1 oligomerization and phosphorylation. Activated IRE1 kinase domain ultimately 
induces Jun N-terminal kinase (JNK) phosphorylation and its endoribonuclease domain promotes XBP1 mRNA splicing, originating XBP1s. (B) IRE1 and 
phosphorylated JNK1/2 (P-JNK) were detected by Western blot and (C) quantified by densitometry relative to tubulin in RS, CuSO
4
- and H
2
O
2
-stress-induced 
premature senescence cells. (D) XBP1s relative transcript levels were assessed by qPCR and normalized to TATA box binding protein expression for the 
three cellular models of senescence. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; **p < .01; ***p < .001; and 
n.s. = nonsignificant when compared with control. 
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H
2
O
2
 showed a trend to higher (~1.5-fold) levels of ATF6(p50) when 
compared with controls, but only the lowest dose tested (50  µM) 
yielded a statistically signi"cant variation (p = .04).
ER Stress Response Inhibition Attenuates the 
Appearance of SIPS
The importance of ER stress response activation during cellular 
senescence was evaluated by inhibiting IRE1 or PERK activities in 
WI-38 "broblasts prior to the induction of SIPS. The IRE1 inhibitor 
4µ8c and PERK inhibitor GSK2606414 were already tested in sev-
eral cell lines and were shown to selectively inhibit IRE1-dependent 
XBP1 splicing and eIF2α phosphorylation, respectively (35,36). 
Herein, the ef"cacy of each one of these inhibitors was veri"ed in 
cells treated with dithiothreitol (DTT), a potent ER stress inducer. 
It was demonstrated that the marked increased in XBP1s mRNA 
and p-eIF2α protein levels induced by DTT was greatly prevented 
by the presence of the IRE1 and PERK inhibitors, respectively (see 
Supplementary Figure  1). Because CuSO
4
-SIPS cells exhibit both 
IRE1- and PERK-mediated ER stress response activation (Figures 3 
and 4), whereas H
2
O
2
-SIPS cells just present PERK pathway induc-
tion (Figure 4), IRE1 inhibition with 4µ8c was performed prior to 
SIPS induction with copper sulfate, whereas PERK was inhibited 
with GSK2606414 before SIPS induction with copper sulfate or 
hydrogen peroxide. As presented in Figure  6A, GSK2606414 or 
4µ8c did not affect cell viability. Regarding cell proliferation, PERK 
inhibition with GSK2606414 prior to H
2
O
2
-SIPS induction had no 
effect when compared with H
2
O
2
-treated cells without the inhibi-
tor (Figure 6B). However, pretreatment of CuSO
4
-treated cells with 
GSK2606414 resulted in a statistically signi"cant increase in cell 
proliferation as compared to CuSO
4
-treated cells without the inhibi-
tor (Figure  6C). A  divergent result was obtained using 4µ8c: the 
inhibition of IRE1-mediated ER stress response prior to CuSO
4
-SIPS 
induction did not affect copper ability to inhibit cell proliferation 
(Figure 6D). It is noteworthy to mention that inhibition of IRE1-
pathway per se results in a marked inhibition of cell proliferation in 
WI-38 "broblasts (control vs. control 4µ8c). This anti-proliferative 
effect of 4µ8c was already described in KP4 tumor cell line (36), 
and IRE1 has actually been identi"ed as a cell cycle regulator, as it 
controls cyclin A1 expression promoting cell proliferation through 
XBP1 (37).
To evaluate the effect of ER stress response inhibition in the 
appearance of typical senescence biomarkers, cells were pretreated 
Figure 4. Pancreatic ER kinase (PERK) pathway is activated in H
2
O
2
- and CuSO
4
-stress-induced premature senescence (SIPS) cellular models. (A) Schematic 
representation of the activation of PERK pathway: in endoplasmic reticulum (ER) stress conditions, immunoglobulin binding protein is recruited to assist 
protein folding and releases the ER luminal domain of PERK leading to its oligomerization and phosphorylation. Activated PERK then phosphorylates eIF2α 
(p-eIF2α) inhibiting general protein translation and activating the translation of specific mRNAs such as the transcription factor ATF4, which in turn promotes 
the transcription of CHOP. (B) PERK and p-eIF2α proteins were detected by Western blot and (C) quantified, based on densitometry relative to tubulin in cellular 
extracts from RS, CuSO
4
-, and H
2
O
2
-SIPS models. (D) Relative levels of CHOP mRNA were quantified by qPCR after normalization to TATA box binding protein 
expression in the three cellular models of senescence. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; **p < .01; ***p 
< .001; and n.s. = nonsignificant when compared with control.
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with GSK2606414 or 4µ8c before being exposed to hydrogen perox-
ide or copper sulfate and the percentage of SA beta-gal positive cells 
and p21 mRNA relative levels were quanti"ed. The PERK inhibition 
prior to H
2
O
2
-SIPS induction resulted in a decreased number of cells 
positive for SA beta-gal from 33.7% to 20.1% and in an attenu-
ation of p21 mRNA levels, from 16.4- to 2.1-fold (Figure 7A and 
7C). In addition, PERK- and IRE1-inhibiton prior to cell exposure 
to 350 µM CuSO
4
 resulted in a diminished percentage of positive 
cells for SA beta-gal from 38.6% in CuSO
4
-treated cells to 17.1% 
and 17.2% in the presence of GSK2606414 and 4µ8c, respectively 
(Figure  7B). Moreover, "broblasts treated with 350  µM CuSO
4
 
exhibited a 4.1-fold increase in p21 mRNA relative levels when 
compared with control cells (Figure 7D) and this increase was also 
signi"cantly prevented by the presence of GSK2606414 (2.0-fold). 
Regarding IRE1-pathway inhibition, cells treated with 4µ8c prior to 
CuSO
4
-SIPS induction did not show any signi"cant variation on p21 
transcript levels (3.5-fold) when compared with CuSO
4
-treated cells.
Discussion
This study evaluates the levels of ER chaperoning system interveners 
and the activation of ER stress response during cellular senescence. 
The occurrence of ER stress was reported in human senescence 
induced by tumor-associated mutations (38) or chemotherapeutic 
agents in neoplastic cells (39), but never in nonmodi"ed senescent 
cells in vitro. Using RS, H
2
O
2
- and CuSO
4
-SIPS human cellular 
models, it is shown that BiP, calnexin, PDI, and Ero1 levels are 
adjusted to deal with senescence-associated imbalance in prosteo-
stasis. Moreover, RS triggers a cellular protective ER stress response 
mediated by IRE1, ATF6, and PERK. This behavior is mimicked by 
CuSO
4
-SIPS but not by H
2
O
2
-SIPS, which does not exhibit the acti-
vation of IRE1 and ATF6 axis of ER stress response and, instead, 
reveals PERK-mediated upregulation of CHOP.
The BiP chaperone expression is usually induced when misfolded 
polypeptides accumulate in the ER (40). Aging is likely to result in 
the impairment of this mechanism as BiP expression was lower in the 
liver (6), brain cortex (41), and other tissues (16) of aged rodents. In 
contrast, in this study, the human cellular models of RS and CuSO
4
-
SIPS, but not H
2
O
2
-SIPS, had enhanced BiP mRNA and protein lev-
els when compared with controls. One likely explanation for this 
discrepancy is the effective percentage of senescent cells present in 
each case. In fact, aged baboons (42,43), monkeys (44), and humans 
(23) skin biopsies had senescent cells ranging from 0.1% to 15%
of the total number. This implies that most BiP in old tissues results
from nonsenescent cells which precludes a direct comparison of tis-
sue homogenates with the senescent cell enriched in vitro cellular
models. We are convinced that during cellular senescence, either RS
or CuSO
4
-SIPS, moderate oxidative damage on proteins promotes
their misfolding/unfolding and aggregation. In such a proteostasis
disruption condition, ER stress response is activated, leading to
enhanced BiP transcription in an attempt to assist protein folding
and restore proteostasis.
Calnexin and PDI were reduced in aged rodent hippocampus 
(15) and liver (6,14). In addition, calnexin levels in RS and H
2
O
2
-
SIPS "broblasts exhibited signi"cant decrease when compared
with young cells (45). The current investigation con"rmed calnexin
downregulation in the three models and further evidenced a simi-
lar PDI protein change. The Ero1 protein levels variation along
aging, largely unknown so far, evidenced here a senescent-associated
increase, probably as a result of an oxidative stress induced effect on
transcriptional regulation, as reported in yeast (46).
Besides these chaperones and enzymes, aging modulates ER 
stress response components such as the PERK, IRE1, and ATF6 
transmembrane sensors. The ef"ciency of these cell protective path-
ways declines during aging, disturbs protein quality control, and can 
lead to cell death (13–16). Age-related variations in PERK signaling 
Figure 5. Activating transcription factor 6 (ATF6) is activated by proteolytic cleavage in RS and CuSO
4
-stress-induced premature senescence. (A) Schematic 
representation ATF6 branch of endoplasmic reticulum (ER) stress response: as immunoglobulin binding protein (BiP) binds to accumulated misfolded proteins 
in the ER, it releases ATF6 that is then transported to Golgi apparatus. There, the cytosolic domain of ATF6 is cleaved to a 50 kDa form—ATF6(p50)—which 
translocates to the nucleus where it can activate the transcription of X box-binding protein 1, CCAAT/enhancer-binding protein homologous protein, and ER 
chaperones, such as BiP. (B) ATF6(p50) was detected by Western blot and its relative protein levels were obtained by densitometric quantification relative to 
tubulin. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; **p < .01; and n.s. = nonsignificant when compared with control.
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Figure 6. Pancreatic ER kinase (PERK) and inositol-requiring enzyme-1 (IRE1) inhibition prior to stress-induced premature senescence (SIPS) induction does 
not affect cell viability but present differential effects on cell proliferation. (A) Cell viability was assessed using neutral red assay immediately after stress in 
H
2
O
2
- and CuSO
4
-SIPS cells in the presence or absence of PERK (GSK2606414) or IRE1 (4µ8c) inhibitors, assuming that the control condition exhibited 100% 
of viable cells. Cell proliferation was evaluated using in sulforhodamine B assay at 0, 1, 2, 3, and 4 days after stress in (B) H
2
O
2
-SIPS or (C and D) CuSO
4
-SIPS 
cells pre-treated or not with 120 nM GSK2606414 or 10 µM 4µ8c, as indicated in the respective plots. The percentage of cell mass was calculated at the fourth 
day after stress for H
2
O
2
-SIPS and CuSO
4
-SIPS cells in the presence or absence of the inhibitors, considering that the respective control cells represented 100% 
of cell mass. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; **p < .01; ***p < .001; and n.s. = nonsignificant when 
compared with control. 
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were previously reported, but the results are sparse and con$icting. 
For instance, in aged rats hippocampus, PERK mRNA was down-
regulated (15), whereas PERK protein levels were increased in other 
tissues (16). In addition, it remained to be determined IRE1 or ATF6 
pathways involvement in aging as IRE1 inactivation resulted in 
Caenorhabditis elegans decreased life span (2,47) and no change 
in Saccharomyces cerevisiae (48). This study provides compelling 
evidence that RS and CuSO
4
-SIPS conditions activated IRE1 path-
way, as shown by enhanced expression of IRE1 protein itself and 
its downstream effectors XBP1s mRNA and phosphorylated JNK; 
similarly, a clear rise in ATF6(p50) levels is consequent to ATF6 axis 
activation upon proteolytic cleavage; and PERK pathway activa-
tion was also veri"ed by increased total PERK and p-eIF2α levels, 
although without increased CHOP transcription. In contrast, H
2
O
2
-
SIPS "broblasts do not reveal IRE1 or ATF6 signaling activation, but 
instead they exhibit PERK activation with increased p-eIF2α and 
CHOP overexpression.
These results in RS and CuSO
4
-SIPS models favor the view that 
senescence is accompanied by moderate ER stress which activates 
protective responses, mediated by IRE1, ATF6, and PERK. In this 
case, however, PERK-mediated UPR response activation is not 
upregulating CHOP as it occurs in its most classical view. Instead, 
although uncertain, a differentially regulated PERK-dependent 
response leading to CHOP downregulation may be activated in these 
conditions. In fact, it was recently identi"ed a PERK-responsive 
microRNA (miR-211) that inhibits CHOP expression, allowing cell 
homeostasis re-establishment (49). However, further investigation is 
needed to clarify this point.
Although the pattern of chaperone and ER stress sensors acti-
vation is considerably coherent in RS and CuSO
4
-SIPS, it is not so 
in H
2
O
2
-SIPS model. The latter is the most frequently used in vitro 
model to study molecular events of cellular senescence because it 
largely mimics genotypic and phenotypic features of RS. Surprisingly, 
in this study, H
2
O
2
-treated cells failed to activate two of the ER stress 
response pathways that are triggered in RS. In fact, neither ATF6 nor 
IRE1 pathways were activated in H
2
O
2
-SIPS and, actually, XBP1s 
transcript level decreased in "broblasts treated with H
2
O
2
 highest 
doses. As shown earlier in mesangial cells (50), such oxidant envi-
ronment is likely to affect XBP1s mRNA, which must be stabilized 
to promote an ef"cient IRE1-mediated ER stress response (51). In 
contrast to ATF6 and IRE1, PERK-CHOP pathway is activated in 75 
or 100 μM H
2
O
2
-induced SIPS "broblasts. The CHOP, apart from its 
involvement in ER stress-induced apoptosis (33), was recently rec-
ognized as essential for the transcriptional activation of autophagy 
genes (34), preventing cell death (30). In H
2
O
2
-SIPS, a condition 
where the cells are known to acquire resistance to cell death, the 
slightly overexpressed CHOP might be regulating cytoprotective 
mechanisms as autophagy instead of inducing apoptosis.
Figure 7. Impact of unfolded protein response inhibition prior to stress-induced premature senescence (SIPS) induction in the appearance of the senescent 
biomarkers SA beta-gal and p21 mRNA levels. The percentage of cells positive for SA beta-gal is plotted for cells in (A) H
2
O
2
-SIPS and (B) CuSO
4
-SIPS in the 
presence or absence of pancreatic ER kinase (PERK) (120 nM GSK2606414) or inositol-requiring enzyme-1 (IRE1) (10 µM 4µ8c) inhibitors. Relative levels of 
p21 mRNA were quantified by qPCR after normalization to TATA box binding protein expression in (C) H
2
O
2
-SIPS or (D) CuSO
4
-SIPS cells treated or not with 
GSK2606414 or 4µ8c, as indicated. Data are expressed as mean ± SEM from at least three independent experiments. *p < .05; ***p < .001; and n.s. = nonsignificant, 
when compared with control.
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The ER acts as a sensor of the physiological state of the cell 
and is able to trigger an ER stress response that will decide cell 
fate. It is shown here that the inhibition of ER stress response 
(either PERK- or IRE1-mediated) before the induction of H
2
O
2
- 
or CuSO
4
-SIPS leads to the attenuation of the appearance of the 
senescence biomarker SA beta-gal. Actually, a similar effect had 
been already described in an oncogene-induced premature senes-
cence model (38). The decrease of CuSO
4
-induced senescence by 
GSK2606414 is reinforced by the increase in cell proliferation 
and decrease in p21 mRNA levels. Actually, PERK activation 
was already associated with cell cycle blockage, as it was shown 
that high levels of eIF2α phosphorylation are able to induce G1 
cell cycle arrest in mouse "broblasts submitted to hypoxia (52). 
Interestingly, PERK inhibition prior to H
2
O
2
-SIPS did not affect 
cell proliferation while p21 is still decreased. These results indicate 
that PERK-mediated ER stress response is implicated in copper 
ability to induce cell cycle arrest in CuSO
4
-SIPS model, whereas 
cell proliferation inhibition by H
2
O
2
 is independent of PERK-
pathway activation. This differential behavior observed between 
CuSO
4
- and H
2
O
2
-SIPS cells, already discussed earlier, may arise 
from the different intensities of stress provoked by each SIPS 
inducer and the alternative pathways they might be activating in 
the cell. The IRE1 inhibition prior to cell exposure to CuSO
4
 did 
not alter the effect of copper sulfate on cell proliferation or p21 
mRNA levels. Together, the data shown here indicate that the cell 
cycle arrest occurring in CuSO
4
-SIPS cells is mediated by PERK 
activation but does not require IRE1 activity.
This study shows that CuSO
4
-SIPS model mimics better the ER 
molecular events of RS than H
2
O
2
-SIPS and adds further evidence 
on the molecular mechanisms that regulate the induction of senes-
cence. Copper has recently been involved in the establishment of 
senescence, because its intracellular levels were increased in RS 
"broblasts when compared with young cells (53). Such involve-
ment can be now justi"ed by copper ability to induce the activation 
of ER stress response, which we demonstrate here to be required 
for the induction of senescence. Actually, copper homeostasis dis-
ruption has been involved in age-related diseases, as Alzheimer’s 
and Parkinson’s (for a review, see Ref. (54)), which turns copper-
induced senescence model a valuable tool in their study. In addi-
tion, its usefulness may extend to identify new mechanisms and 
potential targets for pharmaceutical interventions, aiming to ame-
liorate cellular stress responses during aging and postpone age-
related health deterioration.
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Supplementary Figure 1: IRE1 and PERK inhibitors were able to effectively decrease XBP1s and 
p-eIF2α levels in the presence of DTT. (A) XBP1s mRNA levels were evaluated by qPCR immediately 
after cell exposure to 2 mM DTT for 2h (2hDTT) and after allowing cell recovery from 2hDTT for 3h 
(2hDTT+3h), in the presence or absence of 10 μM 4μ8c. The presence of 4μ8c was able to reduce 
XBP1 splicing from 22- and 30-fold to 0.6- and 2.5-fold in 2hDTT and 2hDTT+3h cells, respectively, 
when compared to control. (B) p-eIF2α protein levels, semi-quantified by western blot, exhibited an 
increase of about 4.5-fold both in 2hDTT and 2hDTT+3h cells, that was inhibited by 30 or 120nM 
GSK2606414 to 2.3- and 1.2-fold respectively in 2hDTT cells, and to 2.9- and 2.4-fold in cells that 
were allowed to recover for 3h after 2hDTT treatment, when compared to control. 
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Copper sulfate-induced premature senescence (CuSO4-SIPS) was found to mimetize molecular mechanisms of replicative 
senescence in a consistent way, particularly at the level of endoplasmic reticulum proteostasis. In fact, disruption of protein 
homeostasis has been recognized as leading to age-related cell and tissue dysfunction, and human disorders susceptibility. 
Resveratrol is a polyphenolic antioxidant compound known to exhibit anti-aging properties under in vitro and in vivo 
particular conditions. In this setting, we aimed at evaluating resveratrol ability to attenuate the induction of cellular 
senescence and to unravel the related, elusive, molecular mechanisms. Using CuSO4-SIPS WI-38 fibroblasts, it is 
demonstrated that resveratrol attenuates typical senescence alterations on cell morphology, senescence-associated beta-
galactosidase activity and cell proliferation. The mechanisms implicated in this anti-senescence effect do not appear to 
involve the regulation of senescence-associated genes and proteins, but are instead reliant on the improvement of cellular 
proteostasis. In fact, resveratrol supplementation restores copper-induced increased total intracellular protein content, 
attenuates BiP chaperone level, and reduces carbonylated and poly-ubiquitinated proteins by lysosomal autophagy induction. 
Our data provide compelling evidence for the beneficial effects of resveratrol by mitigating CuSO4-SIPS stressful 
consequences in human fibroblasts by the modulation of protein quality control systems. These findings highlight the 
importance of a balanced cellular proteostasis and add further knowledge on molecular mechanisms that mediate resveratrol 
anti-senescence effects. Moreover, they contribute to identify specific molecular targets whose modulation is able to prevent 
age-associated cell dysfunction and improve human healthspan. 
Key words: aging, copper, SIPS, resveratrol, human fibroblasts, proteostasis 
Normal somatic dividing cells have been proved to 
be valuable in vitro models to study cellular senescence 
and unravel molecular mechanisms and pathways 
implicated in the human aging process. The well known 
model of replicative senescence (RS) is achieved when 
human diploid fibroblasts (HDFs) spontaneously stop 
dividing after an initial active period of population 
doublings, and become unresponsive to mitogenic 
stimuli (Hayflick & Moorhead 1961). Besides the 
irreversible cell cycle arrest, RS fibroblasts exhibit 
other, typical, morphological and molecular features, 
such as increased cellular volume, higher senescence 
associated beta-galactosidase (SA beta-gal) activity 
and increased expression of senescence-associated 
genes and proteins (Dimri et al. 1995; Debacq-
Chainiaux et al. 2008). A similar senescent phenotype, 
termed stress-induced premature senescence (SIPS), 
can be attained by the exposure of HDFs to 
subcytotoxic doses of oxidative stress inducers such as 
hydrogen peroxide (H2O2-SIPS) (Chen & Ames 1994), 
tert-butyl hydroperoxide, ultra-violet B radiation 
(Debacq-Chainiaux et al. 2008) or copper sulfate 
(CuSO4-SIPS) (Matos et al. 2012). Recently, the latter 
was shown to mimic better the RS model compared to 
the most frequently used H2O2-SIPS model (Matos et 
al. 2014). 
Resveratrol is a natural polyphenolic compound that 
was shown to increase maximum lifespan of several 
organisms, such as Saccharomyces cerevisiae (Howitz 
et al. 2003), Caenorhabditis elegans (Viswanathan et 
al. 2005), Drosophila melanogaster (Wood et al. 2004) 
and the short-lived fish Nothobranchius furzeri 
(Valenzano et al. 2006). Yet, resveratrol failed to 
extend longevity in rodent mammals, even though it 
improved their healthspan, thus evidencing a protective 
role against age-related deterioration (Pearson et al. 
2008). 
At the cellular level, resveratrol has also been shown 
to attenuate senescence features in either RS 
(Giovannelli et al. 2011) or H2O2-SIPS (Demidenko & 
Blagosklonny 2009; Ido et al. 2015) cellular models. 
These anti-aging effects have long been associated to 
resveratrol ability to activate sirtuin1 deacetylase, Sirt1 
(for a review see Bhullar & Hubbard 2015). Actually, 
it was demonstrated that Sirt1 overexpression 
attenuates senescence and extends replicative lifespan 
of several cultured cell types (Ota et al. 2007; Huang et 
al. 2008; Yamashita et al. 2012), while its inhibition 
results in increased cellular senescence (Ota et al. 
2007). Also, Sirt1 was shown to be downregulated with 
aging (Lu et al. 2014) and in cellular senescence 
models (Sasaki et al. 2006; Song et al. 2014) further 
favoring its preventive role of senescence features. 
Besides resveratrol ability to modulate signal 
transduction pathways through the activation of Sirt1 
(Park et al. 2012; Ido et al. 2015), several other 
biological events were assigned as responsible for its 
positive effects, including its ability to increase stress 
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resistance (Giovannelli et al. 2011), to induce 
telomerase activity (Xia et al. 2008), to decrease the 
secretion of senescence-associated pro-inflammatory 
proteins (Csiszar et al. 2012) and to inhibit the 
mechanistic target of rapamycin, mTOR (Demidenko 
& Blagosklonny 2009). Resveratrol was also found to 
modulate protein quality control cellular responses, as 
it was shown to regulate the expression of the heat 
shock molecular chaperones (Putics et al. 2008) and to 
promote cellular protein degradation mechanisms, 
namely ubiquitin-proteasome system (UPS) (Sato et al. 
2013; Regitz et al. 2015) and lysosomal autophagy 
(Duan et al. 2013; Suzuki & Bartlett 2014). Moreover, 
resveratrol was able to increase C. elegans lifespan 
through the upregulation of abu11 (activated in blocked 
unfolded protein response-11), which encodes a protein 
involved in the endoplasmic reticulum (ER) unfolded 
protein response (UPR) that protects the organism from 
damage by improperly folded proteins (Viswanathan et 
al. 2005). 
In the present study we aimed to evaluate the ability 
of resveratrol to attenuate the establishment of cellular 
senescence upon CuSO4 induction, unravelling the 
molecular mechanisms that might be involved. It was 
found that resveratrol supplementation was able to 
reduce the appearance of some senescence-associated 
features by the improvement of cellular proteostasis 
probably by protecting proteins from oxidative damage 
and preventing their accumulation by the induction of 
protein degradation mechanisms.  
RESULTS 
Sirtuin 1 expression is diminished in CuSO4-SIPS 
It was already demonstrated that Sirt1 expression 
decreases with increasing population doublings (Sasaki 
et al. 2006) and also in H2O2-SIPS cellular models 
(Song et al. 2014). Here, Sirt1 transcript and protein 
levels were evaluated by qPCR and western blot, 
respectively, in CuSO4-induced senescent WI-38 
fibroblasts. Similarly to other RS and SIPS models, 
CuSO4-SIPS fibroblasts also presented decreased 
expression of both gene (Fig. 1A) and protein (Fig. 1B) 
Sirt1. Namely, mRNA and protein relative level 
presented a 27% and 23% reduction, respectively, in 
copper-treated cells when compared to controls 
(p=0.04 and p=0.008, respectively). The effect of 
resveratrol (5 or 10 µM), a Sirt1 activator, was 
evaluated 72h after the 24h-incubation of cells with 
CuSO4, which is the usual recovery time that cells need 
to adapt and develop the senescent phenotype (Matos 
et al. 2012). The addition of 10 µM resveratrol 
attenuated the copper-induced decrease in Sirt1 protein 
levels (p=0.047) to values similar to the young control 
cells. Incubation of non CuSO4 submitted fibroblasts 
with 5 and 10 µM resveratrol for 72h increased Sirt1 
protein level by 1.6- and 1.3-fold (p=0.008 and 
p=0.01), respectively, when compared to young control 
cells (Fig. 1B). 
Resveratrol attenuates the appearance of some typical 
senescence-associated alterations  
Senescent cells usually present typical morphological 
alterations, increased level of SA beta-gal and 
irreversible inhibition of cell proliferation. Therefore, 
these three features were evaluated in order to assess 
the effect of resveratrol in CuSO4-SIPS fibroblasts. 
Briefly, cell proliferation was assessed by counting the 
viable cells at 0, 24, 48 and 72h after copper removal. 
Then, at the last time-point (72h), cell morphology was 
observed and the percentage of SA beta-gal positive 
cells was quantified for each condition. As shown in 
Fig. 2A, in the absence of resveratrol, CuSO4-SIPS 
fibroblasts presented the typical senescent morphology, 
as they were no longer small and fusiform and became 
enlarged and flattened. However, copper-treated cells 
recovering in the presence of resveratrol exhibited less 
pronounced senescent-like alterations, as they appeared 
thinner and more elongated, when compared to cells in 
the absence of resveratrol. This was particularly evident 
for the highest concentration of resveratrol used (10 
µM). It is noteworthy to mention that even cells not 
submitted to copper exhibited a slightly different aspect 
Figure 1: Reduced sirtuin 1 expression in CuSO4-SIPS fibroblasts is restored by the addition of resveratrol. (A-B) WI-38 fibroblasts 
were incubated with 350 µM CuSO4 (or Na2SO4, for controls) for 24h. Then, media were changed and cells were allowed to recover for an 
additional 72h period in the presence of 5 or 10 µM resveratrol (or 0,1% DMSO, for controls). After this recovery period, fibroblasts were 
processed for different assays. (A) Sirtuin 1 (Sirt1) transcript levels were assessed by qPCR and plotted assuming that mRNA level of controls 
equals 1. TBP was the selected housekeeping gene. (B) Sirt1 relative protein content was determined by western blot, using Ponceau S staining 
to normalize protein loading. Depicted blots are representative and densitometric quantification is plotted assuming that control cells in the 
absence of resveratrol presents a relative protein level of 1. Data represent mean ± SEM of at least three independent experiments. * p<0.05; 
and ** p<0.01, when compared to control cells in the absence of resveratrol; # p<0.05, relatively to CuSO4-treated cells without resveratrol.  
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in the presence of resveratrol, as they seemed smaller 
and their cell limits were more clear-cut. 
 Similar to previously reported results (Matos et al. 
2014), CuSO4-SIPS cellular model contained 34% of 
cells positive for SA beta-gal (Fig. 2B), whereas the 
controls had only 5% of senescent cells. However, the 
addition of 5 and 10 µM resveratrol to copper-treated 
cells resulted in a statistically significant reduction in 
the number of SA beta-gal positive cells (to 16 and 
14%, respectively). The ability of copper sulfate to 
inhibit cell proliferation had previously been described 
(Matos et al. 2014) and herein is again demonstrated 
(Fig. 2C), as 3 days after stress, copper-treated cells 
presented a reduction of 88% in their proliferation 
when compared to controls. Media supplementation 
with 5 and 10 µM resveratrol during the recovery 
period resulted in the attenuation of cell proliferation 
inhibition by 20 and 34%, respectively. In addition, in 
the absence of copper, the selected concentrations of 
resveratrol were not able to affect significantly cell 
proliferation when compared to control cells. 
Altogether, these data show that resveratrol can 
actually attenuate the induction of senescence by 
copper sulfate in WI-38 fibroblasts. 
Resveratrol does not alter copper-induced 
upregulation of senescence-associated genes and 
proteins 
There are several genes and proteins, such as the 
cyclin-dependent kinase inhibitor 1A (p21), 
apolipoprotein J (ApoJ) and transforming growth factor 
beta 1 (TGFβ1), whose overexpression is typical of the 
senescent phenotype observed in RS and SIPS cellular 
models. Herein, we evaluated the ability of resveratrol 
to adjust the levels of p21, ApoJ and TGFβ1 upon 
copper treatment, in order to justify its effect in the 
attenuation of copper-induced senescence. Therefore, 
Figure 2: Resveratrol attenuates the appearance of typical senescence-associated features induced by CuSO4. (A) Cell morphology was 
evaluated 72h after the removal of 350µM CuSO4 (or Na2SO4, for controls) in fibroblasts that were allowed to recover in the presence or 
absence of 5 or 10 µM resveratrol. Representative images from the indicated conditions are depicted. (B) Senescence-associated beta-
galactosidase (SA beta-gal) activity was detected 72h after CuSO4 removal and the percentage of positive cells was calculated for each 
condition after counting a minimum of 400 cells/well. (C) Cell proliferation was assessed by counting the viable cells in a Neubauer chamber 
at different time-points after CuSO4 treatment (0, 24, 48, and 72h). To facilitate direct comparison between the indicated conditions along 
time, the number of viable cells at day 0 was assumed as 1 for all treatments. Data represent mean ± SEM of at least three independent 
experiments.* p<0.05; and ** p<0.01, when compared to CuSO4-treated cells without resveratrol at the respective time-point. 
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the mRNA transcript relative levels of these genes were 
quantified by qPCR (Fig. 3A). In accordance to 
previous publication (Matos et al. 2012), p21, ApoJ and 
TGFβ1 mRNA levels were found upregulated by 2.2-, 
1.6- and 1.6-fold, respectively, in CuSO4-SIPS 
fibroblasts when compared to control cells. However, 
the addition of resveratrol (either 5 or 10 µM) 
immediately after copper sulfate removal did not have 
any statistically significant effect on the transcript 
levels of these genes. To validate these results and 
exclude the occurrence of post-translational regulation, 
the relative protein levels pf p21 and ApoJ were 
evaluated by western blot (Fig. 3B). At the protein 
level, p21 and ApoJ presented a 3.2- and 1.8-fold 
increase in copper-treated cells, when compared to 
controls, thus confirming the previously noticed trend. 
In addition, similarly to transcript levels results, 
resveratrol supplementation did not affect copper-
induced augmentation of these proteins. Overall, the 
effect of resveratrol in the attenuation of copper-
induced senescence does not involve the regulation of 
p21, ApoJ and TGFβ1 senescence-associated genes. 
Figure 3: Resveratrol supplementation does not affect copper-induced expression of senescence-associated molecules. (A) Transcript 
relative levels of cyclin-dependent kinase inhibitor 1A (p21), apolipoprotein J (ApoJ) and transforming growth factor beta 1 (TGFβ1) were 
assessed by qPCR in 350 µM CuSO4-treated fibroblasts that were allowed to recover in the presence of the indicated doses of resveratrol. (B) 
Representative blots obtained for the determination of p21 and ApoJ protein level by western blot are depicted; the resulting densitometric 
analysis, normalized for control cells in the absence of resveratrol, is plotted for each analysed protein. Ponceau S staining was used to control 
protein loading. Data represent mean ± SEM of at least three independent experiments.* p<0.05; ** p<0.01; and ns non-significant, for the 
comparisons between the indicated groups. 
Figure 4: CuSO4-induced proteostasis imbalance is attenuated 
by resveratrol. Protein load index (PLI), used as a measure of 
cellular protein accumulation, was calculated as the ratio between 
total protein content and cell number for each condition, at different 
time-points after CuSO4 treatment (0, 24, 48 and 72h). PLI values 
were normalized for the initial time-point (0h) and the relative values 
are plotted for the indicated conditions. Data represent mean ± SEM 
of at least three independent experiments. * p<0.05, when compared 
to control cells in the absence of resveratrol; # p<0.05; and ## p<0.01, 
relatively to CuSO4-treated cells without resveratrol, at the 
respective time-points. 
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CuSO4-induced proteostasis imbalance is attenuated 
by resveratrol 
The occurrence of proteostasis imbalance is a major 
hallmark of aging (López-Ótin et al. 2013). To measure 
cellular protein accumulation for each experimental 
condition, the ratio between total protein content and 
cell number, here defined as the protein load index 
(PLI), was calculated at 0, 24, 48 and 72h after CuSO4 
removal (sodium sulfate for controls). Assuming that 
immediately after stress removal PLI equals 1, it was 
shown that it significantly increased 1.7-fold at 48 and 
72h time-points in CuSO4-SIPS cells when compared 
to the respective control conditions (Fig. 4). CuSO4-
treated fibroblasts, that were allowed to recover in the 
presence of 5 µM resveratrol, exhibited a statistically 
significant 0.5-fold decrease in PLI at 48h, when 
compared with cells without added resveratrol. 
Moreover, the addition of 10 µM resveratrol after 
copper removal totally reverted PLI to the level of 
controls in the absence of copper at 48h, and presented 
a statistically significant 0.5-fold decrease at 72h, when 
compared to copper-treated cells in the absence of 
resveratrol at the same time-point.  
Figure 5: Resveratrol attenuates copper-induced BiP upregulation, but has no effect on eIF2 phosphorylation or HSP90 and HSP70 
expression. (A) Phosphorylated eukaryotic translation initiation factor 2 (p-eIF2) and (B) immunoglobulin binding protein (BiP), heat shock 
protein (HSP) 90 and HSP70 protein relative levels were determined by western blot at 72h after the removal of 350µM CuSO4 (or Na2SO4, 
for controls) in fibroblasts that were allowed to recover in the presence or absence of resveratrol (5 or 10µM). Representative blots are depicted 
and densitometric quantification is plotted assuming that protein levels of each analysed protein in control cells without resveratrol equals 1. 
Ponceau S staining was used to normalize protein loading. Data represent mean ± SEM of at least three independent experiments. ** p<0.01; 
*** p<0.001; and ns non-significant, for the comparisons between the indicated groups. 
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 To compensate the altered proteostasis, CuSO4-SIPS 
cells present higher levels of phosphorylated eukaryotic 
translation initiation factor 2 (p-eIF2) (Matos et al. 
2014), which inhibits general protein translation and 
allows cells to restore homeostasis. A possible 
explanation for the diminished PLI obtained for copper 
cells recovering in the presence of resveratrol, could be 
an increased inhibition of overall protein synthesis 
caused by higher p-eIF2. When p-eIF2 was quantified 
by western blot (Fig. 5A), as expected it was found 
increased in CuSO4-treated cells, compared to controls. 
However, resveratrol supplementation upon copper 
removal did not result in any additional alteration in p-
eIF2 protein level. Next, cell chaperoning ability was 
evaluated by the quantification of the molecular 
chaperones immunoglobulin binding protein (BiP), 
heat shock protein (HSP) 90 and HSP70 by western blot 
(Fig. 5B). In fact, the intracellular protein levels of BiP, 
HSP90 and HSP70 were found 1.4-, 1.9- and 6.3-fold 
increased in CuSO4-SIPS fibroblasts, when compared 
to control cells. The presence of resveratrol after copper 
removal had no effect on HSP90 and HSP70 protein 
levels comparing to the levels of copper-treated cells 
without resveratrol. However, BiP protein levels were 
diminished (to 1.1-fold) in copper-treated cells that 
were allowed to recover in the presence of 10 µM 
resveratrol, relatively to the condition without 
resveratrol, reflecting a lower need to buffer defective 
or damaged proteins. 
Resveratrol attenuates CuSO4-induced accumulation of 
modified proteins by the induction of lysosomal 
autophagy 
The altered proteostasis observed in CuSO4-SIPS 
fibroblasts could be a consequence of a progressive 
accumulation of oxidatively modified proteins. Protein 
carbonylation is a type of irreversible protein oxidation 
that is frequently used as an indicator of increased 
permanent levels of oxidative stress. Actually, cellular 
senescence models (Baraibar & Friguet 2013) and cells 
treated with oxidative stress inducers (Bollineni et al. 
2014) were both shown to exhibit increased levels of 
carbonylated proteins. Herein, carbonyl protein content 
was evaluated to infer about cellular oxidative status in 
the different experimental conditions. CuSO4-SIPS 
cells presented a statistically significant 13% increase 
(p=0.0017) in the relative levels of carbonylated 
proteins, when compared to control cells (Fig. 6A). The 
addition of 10 µM resveratrol during cell recovery (but 
not 5 µM) was able to attenuate such increase in protein 
oxidation by 34%, a variation that was close to reach 
statistical significance (p=0.054). These data suggest 
that resveratrol may be able to prevent or attenuate the 
accumulation of copper-induced oxidized proteins. 
This may be achieved either by its well described 
antioxidant properties that might prevent protein 
damage or by its ability to modulate protein 
degradation processes. UPS activity is known to be 
reduced during aging. The accumulation of poly-
ubiquitinated (poly-Ub) proteins is usually associated 
with decreased UPS efficiency and, in fact, here it was 
observed a 22% increase in the levels of poly-Ub 
proteins in CuSO4-SIPS fibroblasts (Fig. 6B). In 
addition, resveratrol supplementation (only at 10 µM) 
immediately after copper sulfate removal showed to be 
effective on restoring poly-Ub protein levels to the 
control cells ones, in a statistically significant manner 
(p=0.026).  
Depending on the conformation of the poly-ubiquitin 
chain that they possess, poly-Ub proteins may be 
degraded either in the proteasome or by lysosomal 
macroautophagy (Kirkin et al. 2009), mentioned as 
autophagy from here on in order to simplify. 
Autophagy plays a crucial role in the recycling of 
dysfunctional organelles and damaged protein 
aggregates and it was shown to be induced by 
resveratrol in order to prevent oxidative stress cellular 
damage (Duan et al. 2013; Suzuki & Bartlett 2014). In 
the present study, the induction of autophagy was 
evaluated by the conversion of LC3-I to LC3-II, an 
essential step for autophagosome formation, by 
calculating the ratio of the LC3-II/LC3-I protein levels 
using western blot (Fig. 6C). CuSO4-SIPS cells 
presented a statistically significant 1.4-fold increase in 
LC3-II/LC3-I ratio, when compared to young control 
fibroblasts. Furthermore, cell treatment with 10 µM 
resveratrol after copper removal, further increased this 
ratio (to 1.8-fold, p=0.017), when compared to copper-
treated cells that were allowed to recover in the absence 
of resveratrol. 
DISCUSSION 
The CuSO4-SIPS cellular model has proven to have 
major value for studying molecular events that are 
responsible for the aging process (Matos et al. 2012; 
Boilan et al. 2013; Matos et al. 2014). Furthermore, it 
brought additional evidence supporting copper 
contribution to the age-related functional deterioration 
and to the progression of age-related disorders. The 
present study shows that CuSO4-induced cell 
senescence results in reduced Sirt1 expression. As Sirt1 
is activated by the polyphenolic compound resveratrol, 
the mechanism and possibility of attenuating this 
senescent effect upon Sirt1 was addressed. In fact, it 
was demonstrated that resveratrol supplementation 
attenuated copper-induced appearance of some typical 
senescence features. In addition, the mechanism behind 
such anti-senescence effect of resveratrol was shown to 
involve the modulation of cellular proteostasis either by 
the protection of proteins from oxidative damage or by 
the induction of protein degradation processes.  
The effect of resveratrol on cellular senescence has 
been investigated, but the results are contradictory: 
while some authors reported resveratrol ability to 
attenuate cellular aging (Demidenko & Blagosklonny 
2009; Giovannelli et al. 2011; Ido et al. 2015), others 
showed that it induced the appearance of senescence 
(Rusin et al. 2009; Gao et al. 2011; Luo et al. 2013; 
Kilic Eren et al. 2015). In either case, the molecular 
mechanisms involved in such effects were not fully 
clear. We believe that this discrepancy is explained by 
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the different experimental conditions utilized in these 
studies: resveratrol ability to induce cell senescence 
was often reported using tumor cell lines (Rusin et al. 
2009; Gao et al. 2011; Luo et al. 2013) treated with 
high concentrations of the compound (above 25 µM), 
that in some cases resulted in pro-apoptotic effects 
(Kilic Eren et al. 2015); in turn, anti-aging effects were 
described in non-tumor cell lines, incubated with lower 
doses of resveratrol (Giovannelli et al. 2011). In line 
with these evidences, herein, the administration of 5 or 
10 µM resveratrol immediately after copper sulfate 
removal was able to attenuate the induction of WI-38 
fibroblast cellular senescence, as the percentage of SA 
beta-gal positive cells was decreased, the typical 
Figure 6: CuSO4-induced accumulation of carbonylated and poly-ubiquitinated proteins are reduced by resveratrol, through 
lysosomal autophagy induction. (A) Protein carbonyl content and (B) poly-ubiquitinated (poly-Ub) proteins were evaluated in fibroblasts 
submitted to the indicated conditions by western blot. Representative blots are depicted and densitometric quantification was normalized by 
attributing the value 1 for control cells in the absence of resveratrol. Ponceau S staining was used as protein loading control. (C) Lysosomal 
autophagy was studied by the conversion of LC3-I to LC3-II, a critical step for autophagosome formation. LC3-II/LC3-I ratio was calculated 
upon densitometric quantification and plotted assuming that control cells without resveratrol present a value of 1. Data represent mean ± SEM 
of at least three independent experiments. * p<0.05; ** p<0.01; *** p<0.001 and ns non-significant, for the comparisons between the indicated 
groups. 
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morphological alterations were less evident and the 
blockage of cell cycle was alleviated. However, in this 
study, resveratrol was not able to attenuate copper-
induced upregulation of senescence-associated 
molecules, such as p21, ApoJ and TGFβ1. This 
indicates that the mechanism behind the positive anti-
senescence effects of resveratrol does not involve the 
inhibition of copper-induced expression of such 
senescence-associated genes.  
It was recently reported that both RS and CuSO4-
SIPS models exhibit altered expression of several ER 
molecular chaperones and enzymes and activated ER 
UPR pathways (Matos et al. 2014). Here, CuSO4-SIPS 
fibroblasts exhibited greater total protein content, 
increased expression of BiP, HSP70 and HSP90 
molecular chaperones, a rise on the levels of 
carbonylated proteins and higher amount of poly-
ubiquitinated proteins, adding further evidence to the 
occurrence of proteostasis disruption during 
senescence. In contrast, similar cells that were allowed 
to recover in the presence of resveratrol presented 
improved cellular proteostasis, as their total protein 
levels were similar to controls, BiP chaperone 
expression was attenuated and poly-ubiquitinated 
proteins level was reduced. Altogether, these data 
demonstrated that, in the presence of resveratrol, cells 
were able to circumvent copper-induced disruption of 
cellular proteostasis, intimately related to the 
appearance of the typical senescent phenotype.  
The well documented antioxidant properties of 
resveratrol are the likely contributors to this cell 
proteostasis maintenance effect, as it can protect 
proteins from being oxidized in a concentration and 
time-dependent manner. In fact, using in vitro oxidative 
stressed erythrocytes, resveratrol ability to prevent 
protein oxidation reaches a maximum protective effect 
between 30 and 60 minutes after polyphenolic 
compound addition and is then slightly reduced with 
time (Pandey & Rizvi 2009). In the current study, 
resveratrol supplementation for 72h attenuated the 
amount of carbonylated proteins on copper-treated cells 
in a variation that was close to reach statistical 
significance. A time-course evaluation of protein 
carbonylation along these 72h should add further 
information on the existence of time-dependent 
variations on resveratrol efficiency to protect proteins 
from oxidation. 
Another important resveratrol contribution for the 
modulation of cellular proteostasis is its ability to 
regulate protein degradation mechanisms, such as the 
UPS (Sato et al. 2013; Regitz et al. 2015) or lysosomal 
autophagy (Duan et al. 2013; Suzuki & Bartlett 2014). 
Both mechanisms were shown to be intimately related 
as autophagy is activated to compensate UPS inhibition 
(Wojcik 2013). In brief, autophagy is crucial to degrade 
dysfunctional organelles and damaged protein 
aggregates and involves the formation of 
autophagosomes that are targeted to lysosomes for the 
degradation of their inner content. Autophagosome 
formation occurs in successive stages that depend on 
the concerted action of several proteins (Tanida 2011). 
The cytosolic soluble protein LC3-I is particularly 
important in this process because it is lipidated to 
originate LC3-II, which integrates the autophagosome 
membrane. As such conversion is essential for 
elongation and maturation of the autophagosomes, 
LC3-II/LC3-I ratio is usually used to detect autophagy 
activation. Here, CuSO4-SIPS cells exhibited an 
increase in LC3-I to LC3-II conversion; when allowed 
to recover in the presence of resveratrol LC3-II/LC3-I 
ratio was even higher, indicating an enhanced induction 
of autophagy. These results are in agreement with 
previous in vitro (Lv & Zhou 2012) and in vivo (Duan 
et al. 2013) studies demonstrating that oxidative stress 
conditions promote LC3-II/LC3-I ratio increase, 
further enhanced in the presence of resveratrol. 
Moreover, resveratrol has recently been described as 
able to promote the flux of proteins through the 
autophagosomal-lysosomal pathway, thus attenuating 
the dysfunctional effect of intracellular accumulation of 
damaged or defective proteins (Regitz et al. 2015). This 
promotion is in agreement with the results of the current 
study that favor resveratrol anti-senescence effect 
consequent to  its ability to improve cellular 
proteostasis through autophagy induction. However, 
given the proven crosstalk between autophagy and 
proteasomal degradation (Ding et al. 2003), we cannot 
exclude, in addition, the beneficial effects resulting 
from resveratrol ability to modulate the ubiquitin-
proteasome system. 
In summary, this study demonstrates that resveratrol 
is able to attenuate the induction of cell senescence 
consequent CuSO4 exposure. Such effects result from 
resveratrol ability to promote cellular adaptive 
mechanisms, as autophagy upregulation, that sustain 
cellular proteostasis and confer cellular resistance to 
stress. Cellular proteostasis maintenance was found to 
be crucial to prevent the development of the senescent 
phenotype. These data also uncovers molecular targets 
whose modulation is likely to prevent age-associated 
cell and tissue function deterioration and improve 
human healthspan. 
EXPERIMENTAL PROCEDURES 
Cell culture 
WI-38 human fetal lung fibroblasts were purchased 
from The European Collection of Cell Cultures 
(ECACC) and were cultivated in complete medium 
composed of Basal Medium Eagle (BME) 
supplemented with 10% fetal bovine serum, at 37°C in 
a 5% CO2 humidified atmosphere. WI-38 cells are 
considered to be young below 30 population doublings 
(PDs) and enter senescence at 45 PDs or above. For the 
induction of SIPS with copper sulfate (CuSO4-SIPS), 
subconfluent young WI-38 fibroblasts were exposed to 
350 µM CuSO4 (Na2SO4 for controls) for 24h. Then, 
cells were washed once with phosphate buffered saline 
(PBS) and replaced with fresh complete medium 
containing 5 or 10 µM of resveratrol (R5010-Sigma 
Aldrich®) for an additional 72h period. Control cells 
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were submitted to a final concentration of 0.1% DMSO 
for the same period.  
Cell morphology and SA beta-gal detection 
Cell morphology evaluation was performed 72h after 
copper removal by optical inspection using an inverted 
microscope. To assess the presence of senescent cells, 
SA beta-gal was detected 72h after copper removal as 
already described (Matos et al. 2012). The percentage 
of SA beta-gal positive cells in each condition was 
determined by microscopically counting 400 total 
cells/well from at least three independent experiments. 
Cell proliferation and total protein content 
To assess the effect of the different treatments on cell 
proliferation and total protein content, cell number 
determination and SRB assay (Vichai & Kirtikara 
2006) were performed along time after copper removal. 
Briefly, 3000 cells/well were seeded in 96-well culture 
plates, treated for 24h with CuSO4 (or Na2SO4 for 
controls) and then were analyzed at different time 
points (0, 24, 48 and 72h) while recovering in the 
presence or absence of resveratrol. For cell number 
determination, cells were tripsinized, stained with 
Tripan Blue, and the viable cells were microscopically 
counted in a Neubauer chamber. The total number of 
cells per well for each condition at the different time-
points was calculated and plotted, assuming that at t=0, 
for each condition, cell number equals 1. For the total 
protein content determination, cells were treated with 
10% trichloroacetic acid (TCA), 1 hour at 4°C. The 
TCA-precipitated proteins fixed at the bottom of the 
wells were stained for 30 minutes with 0.057% (w/v) 
SRB in 1% acetic acid solution and then washed four 
times with 1% acetic acid. Bound dye was solubilized 
with 10 mM Tris base solution and the absorbance at 
510 nm of each well was recorded using a microplate 
reader (Infinite 200 - TECAN).  
Real time PCR 
Gene expression experiments were performed 72h 
after copper sulfate treatment by real time quantitative 
PCR (qPCR). Total RNA extracted (PureLink® RNA 
Mini Kit, Ambion) from cells derived from at least 
three independent cultures from each condition was 
converted into cDNA by reverse transcription reaction. 
Amplification reaction assays contained SYBR Green 
Mastermix (SYBR® Select Master Mix, Applied 
Biosystems®), 50 ng cDNA and primers (STAB 
VIDA, Lda.) at optimal concentrations. The primer 
sequences were: p21, 5’-CTGGAGACTCTCAGGGT 
CGAA and 5’-CCAGGACTGCAGGCTTCCT; ApoJ, 
5’-GGATGAAGGACCAGTGTGACAAG-3’ and 5’-
CAGCGACCTGGAGGGATTC-3’; TGFβ1, 5’-AGG 
GCTACCATGCCAACTTCT-3’ and 5’-CCGGGTTA 
TGCTGGTTGT ACA-3’; and TATA box binding 
protein (TBP), 5’-TCAAACCCAGAATTGTTCTCCT 
TAT-3’ and 5’-CCTGAATCCCTTTAGAATAGGG 
TAGA-3’. The protocol used for qPCR was: 95°C (3 
min); 40 cycles of 95°C (15 sec) and 60°C (1 min). 
qPCR was performed in the StepOnePlus™ thermal 
cycler (Applied Biosystems™). TBP was the selected 
housekeeping gene when calculating relative transcript 
levels of the target genes.  
Western blot 
Protein levels were assessed 72h after copper sulfate 
exposure by Western blot analysis. WI-38 cells 
submitted to the different treatments were washed with 
PBS and scrapped on ice in a lysis buffer (10 mM Tris, 
pH 7.4, 100 mM NaCl, 1 mM EDTA, 0,1% Triton X-
100) supplemented with protease inhibitors cocktail
(Sigma-Aldrich®). Upon Bradford assay, 20 µg (or 10
µg for de detection of carbonylated or poly-Ub
proteins) of protein from each cell extract were
resolved by SDS-PAGE. Proteins were blotted into a
nitrocellulose membrane and, after blocking with 5%
non-fat dry milk diluted in Tris-buffered saline- 0,1%
tween 20 (TBST), were probed with specific primary
antibodies (anti-HSP90 ab13495, abcam®; anti-LC3
NB100-2220, Novus Biologicals; anti-ubiquitin
PW0930, Enzo® Life Sciences; anti-p21 #2946, anti-
phospho-eIF2 #3398, anti-HSP70 #4876 and anti-BiP
#3177, Cell Signaling Technology®) overnight at pre-
determined optimal dilutions. For the specific detection
of carbonylated proteins, immediately after protein
transfer, the nitrocellulose-bound proteins were treated
as described elsewhere (Castro et al. 2012). Briefly, the
membranes were equilibrated in 20% methanol in TBS,
washed for 5 min with 10% trifluoroacetic acid (TFA),
derivatized with 5 mM 2,4-dinitrophenylhydrazine
(DNPH, Sigma-Aldrich®) diluted in 10% TFA for 10
min (protected from light), washed with 10% TFA to
remove the excess of DNPH, and finally washed with
50% methanol. Following this procedure, the
membranes were blocked with 5% bovine serum
albumin in TBST and incubated with primary anti-DNP
antibody (D9656, Sigma-Aldrich®). From here on, the
western blot procedure was similar to all antibodies:
after TBST washing, immunoblots were incubated with
the appropriate peroxidase-conjugated secondary
antibodies for 1h, detected using ECL western blotting
substrate (Pierce™ - Thermo Scientific) and visualized
in ChemiDocTM XRS (BioRad Laboratories). Results
were quantified by densitometry using the Image Lab®
software. Protein loading was normalized using
Ponceau S protein staining, but similar data were also
obtained using tubulin detection (data not shown).
Statistical analysis 
Student’s t-test was used to compare the means 
between two different conditions. A p-value lower than 
0.05 was considered statistically significant. 
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The involvement of copper in ageing has long been suggested, since alterations on 
copper homeostasis leading to the increase of its levels have been described along ageing 
and in age-associated diseases (Harman, 1965, Sohler and Pfeiffer, 1987, Jimenez-Jimenez 
et al., 1992, Brewer et al., 2010). However, the actual role of copper in the age-associated 
progressive deterioration has remained unclear, although it was believed to mediate ROS 
generation, resulting in increased oxidative stress and its harmful impacts on cellular 
function. 
Departing from this idea, it was hypothesized that copper-induced oxidative stress 
would be able to induce premature senescence in human fibroblasts in culture. In fact, for 
the first time, it is shown here that WI-38 fibroblasts exposed to a subcytotoxic 
concentration of copper sulfate exhibit a set of typical senescence features that resulted in 
the establishment and characterization of a novel SIPS model, the CuSO4-SIPS (Publication 
I). In addition, this cellular model was used to unravel molecular events behind copper 
contribution for cellular senescence; these were shown to involve proteostasis disruption 
(Publication II and III) and the activation of UPR pathways (Publication II). Further 
supporting these findings, the induction of autophagy, and consequent improvement of 
cellular proteostasis by resveratrol, was found to attenuate copper-induced cellular 
senescence and provided further insights on cell response to proteostasis impairment 
(Publication III). 
MAJOR GOALS IN AGEING RESEARCH 
Ageing has been subjected to extensive research in an attempt to clearly determine 
its underlying molecular and cellular events. As it is characterized by a progressive 
physiological decline and increased susceptibility to the establishment of chronic diseases, 
understanding the ageing process will certainly have profound implications for the quality 
of human health. Indeed, the current paradigm of ageing research emphasizes that instead 
of trying to find illusory anti-ageing treatments to prolong longevity, it essentially aims at 
developing realistic methods to extend healthspan, i.e. to ameliorate health throughout 
lifespan and delay the development of diseases. Generally, efforts to improve healthspan 
implicate the attenuation of biological processes known to contribute to ageing, such as 
mitochondrial dysfunction, increased oxidative stress, impaired proteostasis and increased 
senescence. 
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Given the proved contribution of increased oxidative stress to ageing, the use of 
antioxidants has been tested in an attempt to increase healthspan and delay ageing. 
However, evidence from studies using several organism models from yeast to rodent 
mammals are diverse and often contradictory (as reviewed in: Sadowska-Bartosz and 
Bartosz, 2014). In addition, a meta-analysis of randomized trials involving more than 
230,000 participants consuming diverse antioxidants, namely vitamin A, vitamin C, vitamin 
E, beta-carotene or selenium, either individually or in combination, failed to uncover 
longevity benefits from such supplementation and led authors to conclude that some 
antioxidants could actually be related to increased mortality (Bjelakovic et al., 2007). The 
ability of dietary antioxidant supplementation to delay or prevent the appearance of age-
associated disorders, such as age-related macular degeneration, atherosclerosis and 
Alzheimer disease, was also investigated but resulted in contradictory findings as well 
(Chong et al., 2007, Fusco et al., 2007). Altogether, existing data do not support the 
recommendation of diet supplementation with antioxidants as a tool to delay or prevent the 
appearance of age-related pathophysiological alterations and improve healthspan. 
Moreover, beyond the logical concerns about their actual efficacy, it is also critical to assure 
their safety.  
An alternative to circumvent the lack of consistency obtained from the studies with 
antioxidants may be the use of more specific and site-directed approaches, aiming at 
preventing the age-related deterioration of cellular and tissue function. The strategy is to 
foster the knowledge on mechanisms and molecules that contribute to age-related 
functional decline, to identify specific targets and to develop suitable pharmaceutical 
compounds. 
The accumulation of senescent cells in vivo is believed to add to the age-related 
functional deterioration, as they may affect tissue homeostasis and function. In contrast, the 
selective elimination of in vivo accumulating senescent cells has been described to delay the 
progression of age-associated disorders and extend healthspan in mice (Baker et al., 2011). 
More recently, a new class of drugs termed senolytic agents, i.e. compounds that specifically 
eliminate senescent cells in vivo, have been investigated. Actually, the use of desatinib and 
quercetin in combination was able to reduce the appearance of senescent cells and to 
improve healthspan in chronologically aged and a progeroid strain of mice (Zhu et al., 2015). 
Briefly, in this latter study, desatinib and quercetin were selected from a pool of several 
candidate drugs that target anti-apoptotic molecules that were shown to be upregulated in 
senescent cells, such as the ephrins (EFNB1 or 3) and phosphoinositide 3-kinase delta 
catalytic subunit (PI3K). Desatinib is an inhibitor of various tyrosine kinases that is used 
for treating cancers (Montero et al., 2011), and interferes with EFNB-dependent 
suppression of apoptosis (Chang et al., 2008), while quercetin is a natural flavonol known 
to inhibit PI3K and other kinases (Bruning, 2013). In combination, these two drugs proved 
to be effective to eliminate senescent cells and delay the appearance of age-related 
deterioration symptoms and pathological conditions in mice.  
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Thus, as eliminating senescent cells in vivo is a promising approach to improve 
human healthspan, finding molecules that actively intervene in cellular senescence 
induction is crucial to develop specific and site-directed senolytic compounds. As an 
example, an exhaustive proteomic study of the CuSO4-SIPS model or other, should add 
valuable information on the differential protein expression profile of senescent cells and 
provide hints on the cellular pathways involved. In fact, previous studies in RS fibroblasts 
identified expression changes in components of the cytoskeleton, modulators of energy 
production and metabolism, and proteostasis regulators (Trougakos et al., 2006, Aan et al., 
2013). However, recent technologic advances, employing other proteomic approaches, 
allowed a deeper characterization of cellular proteome (Calabrese et al., 2015), that in RS 
endothelial cells, yielded a significantly higher amount of proteins differentially expressed 
in senescence (Yentrapalli et al., 2015).  
A similar proteomic study to compare results obtained with RS cells and CuSO4-SIPS 
fibroblasts might bring further insights on this issue. These include the identification of 
senescence pathways and the evidence of proteins that are exclusive to senescent cells 
membranes. In addition, considering the altered ER proteostasis that accompanies cellular 
senescence (Publication II and III), the study may be used in the assessment of likely 
glycosylation errors occurring in the ER or the Golgi complex, purposed to identify proteins 
with altered glycan branches, having potential biomarker properties. This possibility is 
being explored for tumor cells that secrete or express proteins with aberrant glycosylation 
patterns at their surface (Tuccillo et al., 2014). 
COPPER AND AGEING 
Copper levels have been repeatedly shown to increase with ageing (Harman, 1965, 
Sohler and Pfeiffer, 1987) and in age-associated diseases (Jimenez-Jimenez et al., 1992, 
Brewer et al., 2010). Moreover, tissues from aged individuals or from patients with age-
associated diseases have been shown to accumulate senescent cells (Dimri et al., 1995, 
Paradis et al., 2001, Minamino et al., 2002, Sone and Kagawa, 2005, Gorgoulis et al., 2005, 
Ressler et al., 2006, Erusalimsky, 2009, Babizhayev et al., 2011, Benisch et al., 2012, 
Markowski et al., 2013, Malavolta et al., 2013). Such cells remain metabolically active and, 
as they persist and accumulate along time, can affect their surrounding environment and 
lead to tissue dysfunction (Parrinello et al., 2005, Coppe et al., 2008, Acosta et al., 2013). In 
the present work, copper is shown to promote cellular senescence in human fibroblasts 
(Publication I) and foster UPR response through molecular mechanisms similar to RS 
(Publication II).  
It is conceivable that the enhanced levels of copper along the organism ageing and 
the consequences on cell cultures here reported extrapolate to the in vivo condition, and 
thus contribute to the enhanced percentage of senescent cells within tissues. In turn, the 
accumulation of such copper-induced senescent cells would impact on tissue function and 
lead to the age-related gradual functional deterioration and increased susceptibility to 
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illness. Actually, there is some evidence supporting such hypothetical in vivo copper 
contribution to ageing. 
Wilson disease (WD) is an autosomal recessive disorder characterized by an 
increased deposition of copper in the liver that is caused by mutations in ATP7B gene, which 
encodes a P-type adenosine triphosphatase (ATPase) that is responsible for moving copper 
across hepatocyte intracellular membranes and for its excretion to the bile. In case of 
mutations in ATP7B, these functions are affected and circulating copper levels are found 
decreased while copper accumulates within the hepatocytes. When the hepatocellular 
storage capacity is exceeded, copper is slowly released into circulation and deposited in 
multiple organs, particularly the brain, the eyes and the kidneys (De Bie et al., 2007). 
Therefore, the clinical manifestations of WD may include hepatic abnormalities, ophthalmic 
changes, neurologic defects and psychiatric alterations (Ala et al., 2007). Using liver biopsies 
of WD patients, the occurrence of premature, age-related mitochondrial DNA oxidation was 
reported as consequent to the pro-oxidant effect of accumulating copper within the 
hepatocytes (Mansouri et al., 1997). A similar copper-induced ageing effect was verified at 
the organismal level, as flies chronically exposed to copper exhibited neurologic alterations 
and decreased lifespan when compared to controls (Arcaya et al., 2013).  
Adding support to copper contribution for age-related functional decline, the 
involvement of copper in age-associated diseases has also been explored. In fact, both type 
II diabetes and AD are conditions usually associated with systemic copper excess (Eaton 
and Qian, 2002, Squitti et al., 2005, Brewer et al., 2010), although the mechanisms causing 
such imbalance are not clear. Thus, the use of therapeutic strategies intended to reduce 
circulating copper levels was proposed to prevent or delay health deterioration in these two 
diseases (Cooper et al., 2004, Cooper, 2012, Squitti et al., 2014, Robert et al., 2015).  
Despite the well documented detrimental effects of excess copper, its depletion 
greatly impacts on cellular functions as well. In fact, copper is crucial for the activity of 
several enzymes with important functions, such as ceruloplasmin, copper and zinc 
containing SODs and cytochrome c oxidase (as reviewed in: Vest et al., 2013). Menkes 
disease is characterized by systemic copper deficiency and usually results in severe 
neurological symptoms and early death. In these cases copper supplementation has been 
shown to be effective in extending lifespan although not always being able to avoid 
neurologic impairment (Christodoulou et al., 1998, Munakata et al., 2005, Lenartowicz et al., 
2010).  
Altogether, these data bring relevance to the role of copper in the modulation of 
critical cellular functions, which may ultimately impinge on organismal healthspan and 
longevity. Thus, the novel CuSO4-SIPS model here presented constitute a valuable 
experimental tool to characterize copper-mediated molecular mechanisms and to identify 
targets liable to be modulated hoping to prevent or attenuate age-associated cellular 
dysfunction. 
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LOSS OF PROTEOSTASIS AND THE AGEING PROCESS 
Understanding the complex molecular events that intervene in the ageing process 
could have profound implications for the quality of human health. Both health- and lifespan 
depend on the ability of cells and tissues to adapt, resist and maintain their functions upon 
age-related stressful conditions. However, cellular stress responses are often compromised 
in ageing and so, they frequently associate with the onset of age-associated pathologies.  
Together, the occurrence of oxidative damage upon cellular proteins (Levine and Stadtman, 
2001, Hipkiss, 2006) combined with the decreased efficiency of cellular chaperoning 
systems (Macario and Conway De Macario, 2002) result in loss of proteostasis, pointed out 
as a major hallmark of ageing and several age-associated diseases (López-Ótin et al., 2013). 
In addition, it was suggested that proteostasis disruption represents an early molecular 
event in C. elegans ageing (Ben-Zvi et al., 2009) and is part of a programmed proteostasis 
network remodeling, instead of being a purely stochastic phenomenon (Labbadia and 
Morimoto, 2015). Therefore, unraveling the specific molecular mechanisms that contribute 
to proteostasis disruption during ageing may shed light on potential therapeutic targets 
aiming to delay age-associated health deterioration.  
The results here presented add information on the involvement of protein quality 
control cellular processes that result in cellular senescence establishment. In fact, cellular 
proteostasis is altered in CuSO4-SIPS fibroblasts as they exhibit the activation of UPR 
pathways (Publication II) and the increase of total protein content (Publication III). Also 
shown is that the induction of cellular senescence requires copper-induced cell cycle arrest 
dependently on PERK activation (Publication II). In accordance, at the organismal level (C. 
elegans and D. melanogaster) it has been demonstrated that the specific regulation of UPR 
cellular pathways improves healthspan and leads to lifespan extension (Taylor and Dillin, 
2013, Wang et al., 2015). Moreover, the increased expression of molecular chaperones 
usually correlate with increased stress resistance and extended lifespan in worms (Walker 
and Lithgow, 2003, Hsu et al., 2003) and flies (Morrow et al., 2004), while the impairment 
of protein quality control systems result in accelerated ageing in mice (Min et al., 2008). 
Likewise, improvement of proteostasis by the use of autophagy or proteasome activators 
was also able to extend longevity in yeast, worms and flies (Eisenberg et al., 2009, Bjedov et 
al., 2010, Liu et al., 2011, Vilchez et al., 2012) and to delay ageing functional failure in mice 
(Zhang and Cuervo, 2008).  
In the current study, the use of resveratrol is shown to ameliorate cellular 
proteostasis in CuSO4-fibroblasts by the activation of lysosomal autophagy, resulting in the 
attenuation of cellular senescence (Publication III). In line with these findings, there are 
studies reporting the ability of resveratrol to regulate protein degradation mechanisms, 
such as lysosomal autophagy (Duan et al., 2013, Guo et al., 2013, Suzuki and Bartlett, 2014, 
Dutta et al., 2014) and the ubiquitin-proteasome system (Marambaud et al., 2005, Niu et al., 
2011, Sato et al., 2013, Chothe and Swaan, 2014, Regitz et al., 2015). Understanding the 
exact mode of action of resveratrol on such protein quality control mechanisms is important 
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to identify specific ways to modulate the molecular targets involved in the ageing process. 
Here, the CuSO4-SIPS model revealed to be of most value to unravel such molecular 
interveners, as it mimics the molecular events regarding the alterations on cellular 
proteostasis that occur in RS. In contrast, the H2O2-SIPS model, which is the most frequently 
utilized for these studies, was shown to exhibit a different molecular profile even though it 
presents senescent phenotype alterations that resemble RS (Publication II). 
The occurrence of cellular proteostasis disruption in ageing and age-associated 
disorders has been repeatedly demonstrated and, in part, it may be a consequence of the 
age-related progressive loss of efficiency of molecular chaperoning and cellular protein 
degradation mechanisms. The work presented in this thesis confirms the involvement of 
proteostasis disruption in the induction of cellular senescence and shows that improving 
cellular proteostasis through autophagy activation attenuates the appearance of some 
typical senescence features (Publication III).  
The findings support the view that activation of protein degradation mechanisms is 
a promising approach to delay ageing and improve healthspan (Rubinsztein et al., 2011, 
Chondrogianni et al., 2015). Such approach may lead to a general improvement of cellular 
and tissue proteostasis and, in line with the findings of the present work, it may be able to 
prevent the appearance and accumulation of senescent cells in organismal tissues.  
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